var title_f21_12_21696="Palpating the plantar fascia";
var content_f21_12_21696=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F76161&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F76161&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Palpating the plantar fascia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 363px; height: 282px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The toes are grasped and dorsiflexed with one hand, while the other hand palpates the plantar aspect of the foot, particularly the bands compressing the plantar fascia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert P Sheon, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_12_21696=[""].join("\n");
var outline_f21_12_21696=null;
var title_f21_12_21697="Ingrown toenail PI";
var content_f21_12_21697=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F78487&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F78487&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ingrown toenail",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 338px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    You can get an&nbsp;ingrown toenail if the side or corner of your toenail grows into the flesh of that toe.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Stedman's Medical Dictionary. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_12_21697=[""].join("\n");
var outline_f21_12_21697=null;
var title_f21_12_21698="Closure vaginal mucosa";
var content_f21_12_21698=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F66835&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F66835&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Closure of the vaginal mucosa during vaginal hysterectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 414px; height: 369px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_12_21698=[""].join("\n");
var outline_f21_12_21698=null;
var title_f21_12_21699="Tiopronin: Drug information";
var content_f21_12_21699=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Tiopronin: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?19/50/20260?source=see_link\">",
"    see \"Tiopronin: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F228218\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Thiola&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F228232\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Urinary Tract Product",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F228220\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Dosage should be adjusted to reduce urinary cystine level to below the solubility limit (generally &lt;250 mg/L).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Prevention of nephrolithiasis (cystine):",
"     </b>",
"     Oral: Initial: 800 mg/day in 3 divided doses; average dose: 1000 mg/day",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F12595418\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Dosage should be adjusted to reduce urinary cystine level to below the solubility limit (generally &lt;250 mg/L).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Prevention of nephrolithiasis (cystine):",
"     </b>",
"     Oral: Children &ge;9 years: Initial: 15 mg/kg/day in 3 divided doses",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F228221\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F228213\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Thiola&reg;: 100 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F228205\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F12595443\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer 1 hour before or 2 hours after meals. A conservative approach of at least 3 L of fluid intake (ten 10-ounce glassfuls) to achieve a minimum urine output of 2 L/day should be tried prior to initiating therapy; patients continuing to form cystine stones while using this approach may be started on tiopronin. At least 3 L of daily fluid intake should continue while taking tiopronin.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F228214\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prevention of kidney stone (cystine) formation in patients with severe homozygous cystinuria who have urinary cystine &gt;500 mg/day who are resistant to treatment with high fluid intake, alkali and diet modification, or who have had adverse reactions to penicillamine",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F12595364\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Central nervous system: Chills, fatigue, fever",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dermatologic: Bruising, pemphigus, pruritus, rash, skin friability/wrinkling, urticaria, warts",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gastrointestinal: Abdominal pain, anorexia, bloating, diarrhea, flatulence, loss of taste perception, nausea, oral ulceration, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hematologic: Anemia, bleeding, eosinophilia, leukopenia, thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hepatic: Jaundice, liver function tests abnormal",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, myalgia, myasthenia gravis, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Renal: Goodpasture's syndrome, hematuria, nephrotic syndrome, proteinuria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Respiratory: Bronchiolitis, dyspnea, hemoptysis, laryngeal edema, pharyngitis, pulmonary infiltrates, respiratory distress",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Miscellaneous: Elastosis perforans serpiginosa, hypersensitivity, loss of smell, lupus-like syndrome, lymphadenopathy, positive ANA test",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F12593125\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prior history of developing agranulocytosis, aplastic anemia, or thrombocytopenia on this medication; pregnancy, except in severe cystinuria where the benefit of inhibited stone formation outweighs the risk of treatment; breast-feeding",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F12593745\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Goodpasture&rsquo;s syndrome: Penicillamine has rarely been associated with fatalities due to Goodpasture&rsquo;s syndrome; therefore, the potential of Goodpasture&rsquo;s syndrome in tiopronin treated patients is possible; discontinue therapy if signs or symptoms occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Hematologic effects: Signs of toxicity include leukopenia without eosinophilia and thrombocytopenia. Contraindicated in patients with a history of blood dyscrasias (eg, aplastic anemia, agranulocytosis, thrombocytopenia). Advise patients to report early signs and symptoms including fever, sore throat, mouth ulcers, infections, easy bruising, petechial or purpuric hemorrhage. Therapy should be discontinued if platelet count falls to &lt;100,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     or WBC &lt;3500/mm",
"     <sup>",
"      3",
"     </sup>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Myasthenia gravis: Penicillamine has rarely been associated with fatalities due to myasthenia gravis; therefore, the potential of myasthenia gravis in tiopronin-treated patients is possible; discontinue therapy if signs or symptoms occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Pemphigus: Discontinue treatment if pemphigus-type reactions occur; additional therapy may be needed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Proteinuria: Proteinuria may develop; monitor for membranous glomerulopathy which can lead to nephrotic syndrome.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300144\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6223334\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F228210\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F12593115\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects, including skeletal defects and cleft palates, have been observed following penicillamine exposure in animal reproduction studies. Birth defects, including congenital cutix laxa and associated defects, have been reported in infants following penicillamine exposure during pregnancy. Similar effects may be expected with tiopronin; however, animal studies have not shown these same findings. Use is contraindicated during pregnancy; use only if the possible benefits to the mother outweigh the potential risks to the fetus.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F12593123\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/contraindicated",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F12595442\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Should be taken 1 hour before or 2 hours after meals.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F5574863\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Thiola Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (100): $126.00",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F12595452\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     CBC with differential, platelet count, hemoglobin, albumin, liver function tests, 24-hour urinary protein, and routine urinalysis should be performed at 3- to 6-month intervals; urinary cystine 1 month after treatment begins then every 3 months; annual X-ray for renal stones",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F228216\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Acadione (FR);",
"     </li>",
"     <li>",
"      Capen (AR);",
"     </li>",
"     <li>",
"      Captimer (DE);",
"     </li>",
"     <li>",
"      Epatiol (IT);",
"     </li>",
"     <li>",
"      Kai Na (CL);",
"     </li>",
"     <li>",
"      Kai Xi Lai (CL);",
"     </li>",
"     <li>",
"      Mucolysin[chart.] (CH, IT);",
"     </li>",
"     <li>",
"      Mucosyt (IT);",
"     </li>",
"     <li>",
"      Stargen (TW);",
"     </li>",
"     <li>",
"      Sutilan (ES);",
"     </li>",
"     <li>",
"      Thiola (BE, JP);",
"     </li>",
"     <li>",
"      Vincol (ES)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F12595410\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     As an active reducing agent, tiopronin undergoes thiol-disulfide exchange with cystine to form tiopronin-cystine disulfide, which is more water soluble than cystine. As a result, the amount of sparingly soluble cystine in the urine is decreased and the formation of cystine calculi is reduced.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10287 Version 29.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-61.234.146.186-EBC78AF0D7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_12_21699=[""].join("\n");
var outline_f21_12_21699=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228218\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228232\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228220\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12595418\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228221\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228213\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228205\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12595443\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228214\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12595364\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12593125\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12593745\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300144\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6223334\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228210\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12593115\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12593123\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12595442\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5574863\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12595452\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228216\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12595410\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10287\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10287|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?19/50/20260?source=related_link\">",
"      Tiopronin: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_12_21700="Echo of AV canal defect and elongated LVOT";
var content_f21_12_21700=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F86335&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F86335&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Echocardiogram of atrioventricular canal defect with elongated left ventricular outflow tract",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 384px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Echocardiogram in a patient with atrioventricular canal defect and left ventricular outflow tract (LVOT) elongation but without obstruction, as the Doppler detects no flow acceleration (normal blue color).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_12_21700=[""].join("\n");
var outline_f21_12_21700=null;
var title_f21_12_21701="Aliskiren and amlodipine: Patient drug information";
var content_f21_12_21701=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Aliskiren and amlodipine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/36/14919?source=see_link\">",
"     see \"Aliskiren and amlodipine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F11372750\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Tekamlo&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F11372864\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700281",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F11372865\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691888",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high blood pressure.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F11372826\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2989001",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to aliskiren, amlodipine, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3761622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes) and are taking certain drugs for high blood pressure or your heart. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F11372828\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697627",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697100",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a salt substitute that has potassium, potassium-sparing diuretics, or potassium, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your drinking of wine, beer, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696668",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid grapefruit and grapefruit juice.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F11372868\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698148",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High potassium level. Signs include feeling weak, lightheaded, dizzy, feel like passing out, or have numbness or tingling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698360",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling in the arms or legs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698395",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Kidney function that gets worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F11372830\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699070",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of high potassium.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698650",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you have too much sweat, fluid loss, throwing up, or loose stools. This may lead to low blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698670",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, if you get pregnant while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F11372867\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695912",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Always take with food or always take on an empty stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694557",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid taking this drug with high-fat meals.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F11372827\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F11372869\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F11372831\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16075 Version 26.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-817E36F31F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_12_21701=[""].join("\n");
var outline_f21_12_21701=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11372750\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11372864\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11372865\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11372826\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11372828\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11372868\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11372830\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11372867\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11372827\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11372869\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11372831\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?14/36/14919?source=related_link\">",
"      Aliskiren and amlodipine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_12_21702="Seborrheic dermatitis peds";
var content_f21_12_21702=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F55801&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F55801&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Seborrheic dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 315px; height: 498px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Infantile seborrheic dermatitis is commonly called \"cradle cap\" when it occurs on the scalp.",
"    <br/>",
"    (B) Seborrheic dermatitis can affect the scalp, face, ears, neck, and diaper area.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Kenneth Greer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_12_21702=[""].join("\n");
var outline_f21_12_21702=null;
var title_f21_12_21703="Hematologic changes in pregnancy";
var content_f21_12_21703=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hematologic changes in pregnancy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/12/21703/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/12/21703/contributors\">",
"     Kenneth A Bauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/12/21703/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/12/21703/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/12/21703/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/12/21703/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/12/21703/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 21, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal pregnancy is characterized by profound changes in almost every organ system to accommodate the demands of the fetoplacental unit. Hematological adaptation to the pregnant state will be reviewed here; the most significant hematological changes are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Physiologic anemia",
"     </li>",
"     <li>",
"      Neutrophilia",
"     </li>",
"     <li>",
"      Mild thrombocytopenia",
"     </li>",
"     <li>",
"      Increased procoagulant factors",
"     </li>",
"     <li>",
"      Diminished fibrinolysis",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PLASMA VOLUME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plasma volume increases by 10 to 15 percent at 6 to 12 weeks of gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/1-3\">",
"     1-3",
"    </a>",
"    ], expands rapidly until 30 to 34 weeks, after which there is only a modest rise (",
"    <a class=\"graphic graphic_figure graphicRef61948 \" href=\"UTD.htm?9/32/9742\">",
"     figure 1",
"    </a>",
"    ). The total gain at term averages 1100 to 1600 mL and results in a plasma volume of 4700 to 5200 mL, 30 to 50 percent above that found in nonpregnant women [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/1,4\">",
"     1,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    During pregnancy, plasma renin activity tends to be increased and atrial natriuretic peptide levels are slightly reduced. This suggests that the rise in plasma volume is in response to an underfilled vascular system caused by systemic vasodilatation and the rise in vascular capacitance. If expansion of blood volume was the initial event, renal and atrial volume sensors would respond, leading to the opposite hormonal profile (low plasma renin activity, elevated atrial natriuretic peptide) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. This hypothesis is also supported by the observation that increasing sodium intake does not lead to further volume expansion [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Postpartum, plasma volume decreases immediately after delivery, then increases again two to five days later, possibly because of a rise in aldosterone secretion, which occurs at this time. Plasma volume then decreases; it is still elevated by 10 to 15 percent above nonpregnant levels at three weeks postpartum, but is usually at normal nonpregnant levels at six weeks postpartum.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     RED BLOOD CELLS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Red blood cell mass begins to increase at 8 to 10 weeks of gestation and steadily rises by 20 to 30 percent (250 to 450 mL) above nonpregnant levels by the end of pregnancy in women taking iron supplements [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/4,8-11\">",
"     4,8-11",
"    </a>",
"    ]. Among women not on iron supplements, the red cell mass may only increase by 15 to 20 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/12\">",
"     12",
"    </a>",
"    ]. Erythrocyte life span is slightly decreased during normal pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Erythropoietin levels increase by 50 percent in normal pregnancies and vary according to the presence of pregnancy complications [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/14\">",
"     14",
"    </a>",
"    ]. The increased plasma erythropoietin induces the rise in red cell mass, which partially supports the higher metabolic requirement for oxygen during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In women not taking iron supplements, mean corpuscular volume (MCV) decreases during pregnancy and averages 80 to 84 fL in the third trimester [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/16\">",
"     16",
"    </a>",
"    ]. However, MCV increases approximately 4 fL in healthy pregnant women and those with only mild iron deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;A greater expansion of plasma volume relative to the increase in hemoglobin mass and erythrocyte volume is responsible for the modest fall in hemoglobin levels (ie, physiological or dilutional anemia of pregnancy) observed in healthy pregnant women. The greatest disproportion between the rates at which plasma and erythrocytes are added to the maternal circulation occurs during the late second to early third trimester (lowest hemoglobin is typically measured at 28 to 36 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/16\">",
"     16",
"    </a>",
"    ]). Nearer to term, hemoglobin concentration increases due to cessation of plasma expansion and continuing increase in hemoglobin mass (",
"    <a class=\"graphic graphic_figure graphicRef61948 \" href=\"UTD.htm?9/32/9742\">",
"     figure 1",
"    </a>",
"    ). Conversely, the absence of physiologic anemia appears to be a risk factor for stillbirth [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Determining a precise definition of anemia in pregnant women is not straightforward, given the pregnancy associated changes in plasma volume and red cell mass, normal differences in hemoglobin concentrations between women and men, ethnic variation between white and black women, and the frequent use of iron supplementation in pregnancy.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       The Centers for Disease Control and Prevention has defined anemia as hemoglobin levels of less than 11",
"       <span class=\"nowrap\">",
"        g/dL",
"       </span>",
"       (hematocrit less than 33 percent) in the first and third trimesters and less than 10.5",
"       <span class=\"nowrap\">",
"        g/dL",
"       </span>",
"       (hematocrit less than 32 percent) in the second trimester",
"      </strong>",
"      &nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/19\">",
"       19",
"      </a>",
"      ]. Since hemoglobin and hematocrit levels are lower in African-American adults, the Institute of Medicine recommends lowering the hemoglobin cut-off level by 0.8",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      in this population [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The",
"      <strong>",
"       World Health Organization",
"      </strong>",
"      defines anemia in pregnant women as hemoglobin &lt;110",
"      <span class=\"nowrap\">",
"       g/L",
"      </span>",
"      (11",
"      <span class=\"nowrap\">",
"       g/dL)",
"      </span>",
"      or hematocrit &lt;6.83",
"      <span class=\"nowrap\">",
"       mmol/L",
"      </span>",
"      or 0.33",
"      <span class=\"nowrap\">",
"       L/L",
"      </span>",
"      (33 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/21\">",
"       21",
"      </a>",
"      ]. Severe anemia in pregnancy is defined as hemoglobin &lt;70",
"      <span class=\"nowrap\">",
"       g/L",
"      </span>",
"      (7",
"      <span class=\"nowrap\">",
"       g/dL)",
"      </span>",
"      and requires medical treatment. Very severe anaemia is defined as hemoglobin &lt;40",
"      <span class=\"nowrap\">",
"       g/L",
"      </span>",
"      (4",
"      <span class=\"nowrap\">",
"       g/dL)",
"      </span>",
"      and is a medical emergency due to the risk of congestive heart failure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Women with hemoglobin values below these levels can be considered anemic and should undergo a standard evaluation (complete blood count, review of peripheral smear, reticulocyte count, serum",
"    <span class=\"nowrap\">",
"     Fe/TIBC,",
"    </span>",
"    and ferritin) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/22\">",
"     22",
"    </a>",
"    ]. Sixteen to 29 percent of pregnant women in the United States become anemic in the third trimester [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/23\">",
"     23",
"    </a>",
"    ]. If the evaluation is negative, a hemoglobin as low as 10",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    can be attributed to physiologic anemia since a wide variety of factors affects the normal level of hemoglobin in a specific individual. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29418?source=see_link\">",
"     \"Approach to the adult patient with anemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26234?source=see_link&amp;anchor=H27#H27\">",
"     \"Causes and diagnosis of anemia due to iron deficiency\", section on 'Pregnancy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chronic severe anemia is most common in women in developing countries. Maternal hemoglobin below 6",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    has been associated with reduced amniotic fluid volume, fetal cerebral vasodilation, and nonreassuring fetal heart rate patterns [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/24\">",
"     24",
"    </a>",
"    ]. Increased risks of prematurity, spontaneous abortion, low birth weight, and fetal death have also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/25\">",
"     25",
"    </a>",
"    ]. In addition, severe anemia (hemoglobin less than 7",
"    <span class=\"nowrap\">",
"     g/dL)",
"    </span>",
"    increases the risk of maternal mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/26\">",
"     26",
"    </a>",
"    ]. There is no evidence that maternal anemia increases the risk of congenital anomalies in offspring.",
"   </p>",
"   <p>",
"    Chronic severe anemia is usually related to (1) inadequate iron stores due to nutritional deficiency and intestinal helminthic infections, (2) folate deficiency due to inadequate intake, and (3) chronic hemolytic states, such as malaria. Ideally, severe anemia could be prevented and pregnancy outcome improved with nutritional supplementation and infection control measures [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. As an example, a randomized trial in rural China found an iron-",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    supplement (60 mg iron plus 400 mcg folic acid) was associated with higher maternal hemoglobin levels, fewer births before 34 weeks of gestation, and fewer early neonatal deaths than folate alone [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/28\">",
"     28",
"    </a>",
"    ]. However, 40 percent of women were still anemic in the third trimester. A similar trial found that an iron-folic acid supplement given to pregnant Nepalese women in an area where iron deficiency was common appeared to be associated with improvement in some aspects of intellectual and motor function in offspring evaluated at age 7 to 9 years [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Where safe blood transfusion is available, it is probably prudent to treat severe anemia aggressively, as with red cell transfusion, if there are signs suggestive of fetal hypoxemia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Physiologic anemia of pregnancy should resolve by six weeks postpartum since plasma volume has returned to normal by that time. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Plasma volume'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Iron requirements",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a typical singleton gestation, maternal iron requirements average close to 1000 mg over the course of pregnancy: approximately 300 mg for the fetus and placenta and approximately 500 mg, if available, for the expansion of the maternal hemoglobin mass. Two hundred milligrams is shed through the gut, urine, and skin. Since most women do not have adequate iron stores to handle the demands of pregnancy, iron is commonly prescribed as part of a prenatal multivitamin or as a separate supplement. In general, women taking iron supplements have a mean hemoglobin concentration that is 1",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    greater than that of women not taking supplements. Reference ranges for iron indices in pregnancy are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef81137 \" href=\"UTD.htm?37/33/38424\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/44/28362?source=see_link&amp;anchor=H19#H19\">",
"     \"Nutrition in pregnancy\", section on 'Multivitamin and mineral supplements'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Diagnosis, prevention, and treatment of iron deficiency anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;A detailed discussion on the diagnosis, prevention, and management of iron deficiency anemia in pregnant women can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26234?source=see_link&amp;anchor=H27#H27\">",
"     \"Causes and diagnosis of anemia due to iron deficiency\", section on 'Pregnancy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26234?source=see_link&amp;anchor=H42#H42\">",
"     \"Causes and diagnosis of anemia due to iron deficiency\", section on 'Prevention'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/62/25578?source=see_link&amp;anchor=H13#H13\">",
"     \"Treatment of anemia due to iron deficiency\", section on 'Pregnancy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Folate requirements",
"    </span>",
"    &nbsp;&mdash;&nbsp;In nonpregnant individuals, the daily",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    requirement is 50 to 100 mcg. The increase in red cell mass during pregnancy necessitates an increase in the folic acid requirement, but this is more than met by the increased intake (400 to 800 mcg) already recommended for prevention of neural tube defects. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/61/5081?source=see_link\">",
"     \"Folic acid for prevention of neural tube defects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/44/28362?source=see_link\">",
"     \"Nutrition in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PLATELET COUNT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although platelet counts remain in the normal nonpregnant range in most women during uncomplicated pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/30\">",
"     30",
"    </a>",
"    ], mean platelet counts of pregnant women may be slightly lower than in healthy nonpregnant women (",
"    <a class=\"graphic graphic_table graphicRef81137 \" href=\"UTD.htm?37/33/38424\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/31\">",
"     31",
"    </a>",
"    ]. Serial platelet counts during uncomplicated pregnancies may [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/32\">",
"     32",
"    </a>",
"    ] or may not [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/33\">",
"     33",
"    </a>",
"    ] decrease, but the mean values in groups of women do not necessarily reflect changes in individual women [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The platelet count begins to rise soon after delivery and continues to increase for three to four weeks before returning to baseline. In one study of 50 presumably normal",
"    <span class=\"nowrap\">",
"     pregnant/postpartum",
"    </span>",
"    women followed with serial platelet counts, the mean platelet count predelivery and 3, 7, 15, 25, and 42 days after delivery was 219,000; 267,000; 349,000; 363,000; 279,000; and 254,000 per microL, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Thrombocytopenia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most significant obstetrical consideration concerning platelet physiology in pregnancy is thrombocytopenia, which may be related to complications of pregnancy (eg, severe preeclampsia, HELLP syndrome), medical disorders (eg, immune thrombocytopenia [ITP], thrombotic thrombocytopenic purpura-hemolytic uremic syndrome), or gestational thrombocytopenia.",
"   </p>",
"   <p>",
"    Gestational or incidental thrombocytopenia is characterized by mild asymptomatic thrombocytopenia occurring in the third trimester in a patient without any history of thrombocytopenia (other than in a prior pregnancy). It is not associated with maternal, fetal, or neonatal sequelae and spontaneously resolves postpartum [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/36-38\">",
"     36-38",
"    </a>",
"    ]. Platelet counts are typically",
"    <span class=\"nowrap\">",
"     &gt;70,000/microL,",
"    </span>",
"    with about two-thirds being 130,000 to",
"    <span class=\"nowrap\">",
"     150,000/microL.",
"    </span>",
"    Diagnosis and management of gestational thrombocytopenia are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/56/38793?source=see_link\">",
"     \"Thrombocytopenia in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     WHITE BLOOD CELLS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy is associated with leukocytosis, primarily related to increased circulation of neutrophils. The neutrophil count begins to increase in the second month of pregnancy and plateaus in the second or third trimester, at which time the total white blood cell counts range from 9000 to 15,000",
"    <span class=\"nowrap\">",
"     cells/microL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/39\">",
"     39",
"    </a>",
"    ]. Data from two series reported mean white blood cell counts in laboring patients of 10,000 to 16,000",
"    <span class=\"nowrap\">",
"     cells/microL,",
"    </span>",
"    with an upper level as high as 29,000",
"    <span class=\"nowrap\">",
"     cells/microL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]; the mean count increased linearly with the duration of elapsed labor [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/41\">",
"     41",
"    </a>",
"    ]. The white blood cell count falls to the normal nonpregnant range by the sixth day postpartum.",
"   </p>",
"   <p>",
"    Normal pregnant women can have a small number of myelocytes or metamyelocytes in the peripheral circulation. Some studies have observed an increase in the percent of bands as pregnancy advances [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/42-44\">",
"     42-44",
"    </a>",
"    ]. Dohle bodies (blue staining cytoplasmic inclusions in granulocytes) are a normal finding in pregnant women.",
"   </p>",
"   <p>",
"    In healthy women with normal pregnancies, there is no change in the absolute lymphocyte count and no significant changes in the relative numbers of T and B lymphocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/45\">",
"     45",
"    </a>",
"    ]. The monocyte count is generally stable, the basophil count may slightly decrease and the eosinophil count may slightly increase.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     COAGULATION FACTORS AND INHIBITORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal pregnancy is a prothrombotic state [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/46-56\">",
"     46-56",
"    </a>",
"    ]. The following changes occur in circulating levels of coagulation factors (",
"    <a class=\"graphic graphic_table graphicRef81137 \" href=\"UTD.htm?37/33/38424\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Total protein S antigen, free protein S antigen, and protein S activity decrease due to the hormonal changes of pregnancy.",
"     </li>",
"     <li>",
"      Resistance to activated protein C increases in the second and third trimesters.",
"     </li>",
"     <li>",
"      Fibrinogen, factors II, VII, VIII, X, XII, and XIII increase by 20 to 200 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/56,57\">",
"       56,57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Von Willebrand factor increases.",
"     </li>",
"     <li>",
"      Activity of the fibrinolytic inhibitors, thrombin activatable fibrinolytic inhibitor (TAFI), PAI-1, and PAI-2, increases [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/58\">",
"       58",
"      </a>",
"      ]. PAI-1 levels increase markedly.",
"     </li>",
"     <li>",
"      Antithrombin, protein C, Factor V and Factor IX levels remain unchanged or increase slightly [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/56,59\">",
"       56,59",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The net effect of these changes is to increase the tendency for thrombus formation and extension, which results in an increase in venous thrombosis during pregnancy and especially the postpartum period. Along with myometrial contractions and high levels of decidual tissue factor expression, the hypercoagulable state also protects the mother from excessive bleeding at the time of placental separation and delivery.",
"   </p>",
"   <p>",
"    The activated partial thromboplastin time (aPTT) remains in the normal range during pregnancy, but may decrease slightly near term [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/60\">",
"     60",
"    </a>",
"    ]. The prothrombin time (PT) may shorten. Bleeding time does not change [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/61,62\">",
"     61,62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Postpartum, normalization of coagulation parameters varies depending on the factor, but all should return to baseline by six to eight weeks after delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/35\">",
"     35",
"    </a>",
"    ]. Hemostasis probably should not be evaluated earlier than three months following delivery and after terminating lactation to exclude pregnancy-related effects [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The effects of acquired and inherited thrombophilias on pregnancy outcome are controversial and active areas of investigation. These effects are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/5/26714?source=see_link\">",
"     \"Inherited thrombophilias in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H878578652\">",
"    <span class=\"h1\">",
"     POSTPARTUM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy-related hematological changes return to baseline by six to eight weeks after delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21703/abstract/35\">",
"     35",
"    </a>",
"    ]. Within this range, the rate and pattern of resolution of pregnancy-related changes of specific hematological parameters vary and are described above in the section on each parameter.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The major hematological changes during pregnancy are physiologic anemia, neutrophilia, mild thrombocytopenia, increased procoagulant factors, and diminished fibrinolysis. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Plasma volume increases by 10 to 15 percent at 6 to 12 weeks of gestation, and then expands rapidly until 30 to 34 weeks, after which there is only a modest rise (",
"      <a class=\"graphic graphic_figure graphicRef61948 \" href=\"UTD.htm?9/32/9742\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Plasma volume'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Red blood cell mass begins to increase at 8 to 10 weeks of gestation and steadily rises by 20 to 30 percent (250 to 450 mL) above nonpregnant levels by the end of pregnancy. A greater expansion of plasma volume relative to the increase in hemoglobin mass and erythrocyte volume is responsible for the modest fall in hemoglobin levels (ie, physiological or dilutional anemia of pregnancy) observed in healthy pregnant women. The Centers for Disease Control and Prevention has defined anemia as hemoglobin levels of less than 11",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      in the first and third trimesters and less than 10.5",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      in the second trimester. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Red blood cells'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Mean platelet counts of pregnant women may be slightly lower than in healthy nonpregnant women (",
"      <a class=\"graphic graphic_table graphicRef81137 \" href=\"UTD.htm?37/33/38424\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Platelet count'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The neutrophil count begins to increase in the second month of pregnancy and plateaus in the second or third trimester, at which time the total white blood cell counts range from 9000 to 15,000",
"      <span class=\"nowrap\">",
"       cells/microL.",
"      </span>",
"      There is no change in the absolute lymphocyte count. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'White blood cells'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The circulating levels of several coagulation factors change during pregnancy (",
"      <a class=\"graphic graphic_table graphicRef81137 \" href=\"UTD.htm?37/33/38424\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Coagulation factors and inhibitors'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/1\">",
"      Lund CJ, Donovan JC. Blood volume during pregnancy. Significance of plasma and red cell volumes. Am J Obstet Gynecol 1967; 98:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/2\">",
"      Bernstein IM, Ziegler W, Badger GJ. Plasma volume expansion in early pregnancy. Obstet Gynecol 2001; 97:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/3\">",
"      Whittaker PG, Lind T. The intravascular mass of albumin during human pregnancy: a serial study in normal and diabetic women. Br J Obstet Gynaecol 1993; 100:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/4\">",
"      PRITCHARD JA. CHANGES IN THE BLOOD VOLUME DURING PREGNANCY AND DELIVERY. Anesthesiology 1965; 26:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/5\">",
"      Schrier RW. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2). N Engl J Med 1988; 319:1127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/6\">",
"      Nadel AS, Ballermann BJ, Anderson S, Brenner BM. Interrelationships among atrial peptides, renin, and blood volume in pregnant rats. Am J Physiol 1988; 254:R793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/7\">",
"      Lindheimer MD, Katz AI. Sodium and diuretics in pregnancy. N Engl J Med 1973; 288:891.",
"     </a>",
"    </li>",
"    <li>",
"     Metcalfe, J, Stock, MK, Barron, DH. Maternal physiology during gestation. In: the Physiology of Reproduction, Knobil, K, Ewing, L (Eds), Raven Press, New York 1988. p. 2145.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/9\">",
"      McLENNAN CE. Plasma volume late in pregnancy. Am J Obstet Gynecol 1950; 59:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/10\">",
"      Campbell DM, MacGillivray I. Comparison of maternal response in first and second pregnancies in relation to baby weight. J Obstet Gynaecol Br Commonw 1972; 79:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/11\">",
"      Ueland K. Maternal cardiovascular dynamics. VII. Intrapartum blood volume changes. Am J Obstet Gynecol 1976; 126:671.",
"     </a>",
"    </li>",
"    <li>",
"     Hytten, FE, Lind, T. Indices of cardiovascular function. In Hytten FE, Lind T. (eds): Diagnostic indices in pregnancy. Documenta Geigy, Basel 1973.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/13\">",
"      Lurie S, Mamet Y. Red blood cell survival and kinetics during pregnancy. Eur J Obstet Gynecol Reprod Biol 2000; 93:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/14\">",
"      Harstad TW, Mason RA, Cox SM. Serum erythropoietin quantitation in pregnancy using an enzyme-linked immunoassay. Am J Perinatol 1992; 9:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/15\">",
"      Milman N, Graudal N, Nielsen OJ, Agger AO. Serum erythropoietin during normal pregnancy: relationship to hemoglobin and iron status markers and impact of iron supplementation in a longitudinal, placebo-controlled study on 118 women. Int J Hematol 1997; 66:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/16\">",
"      Whittaker PG, Macphail S, Lind T. Serial hematologic changes and pregnancy outcome. Obstet Gynecol 1996; 88:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/17\">",
"      Haram K, Nilsen ST, Ulvik RJ. Iron supplementation in pregnancy--evidence and controversies. Acta Obstet Gynecol Scand 2001; 80:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/18\">",
"      Stephansson O, Dickman PW, Johansson A, Cnattingius S. Maternal hemoglobin concentration during pregnancy and risk of stillbirth. JAMA 2000; 284:2611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/19\">",
"      Centers for Disease Control (CDC). CDC criteria for anemia in children and childbearing-aged women. MMWR Morb Mortal Wkly Rep 1989; 38:400.",
"     </a>",
"    </li>",
"    <li>",
"     Institute of Medicine. Iron deficiency anemia: recommended guidelines for the prevention, detection, and management among US children and women of childbearing age. 1993, Washington, DC.",
"    </li>",
"    <li>",
"     World Health Organization. Iron Deficiency Anaemia. Assessment, Prevention, and Control. A guide for programme managers. 2001. file://www.who.int/nutrition/publications/en/ida_assessment_prevention_control.pdf (Accessed on September 06, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/22\">",
"      American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 95: anemia in pregnancy. Obstet Gynecol 2008; 112:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/23\">",
"      Bailit JL, Doty E, Todia W. Repeated hematocrit measurements in low-risk pregnant women. J Reprod Med 2007; 52:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/24\">",
"      Carles G, Tobal N, Raynal P, et al. Doppler assessment of the fetal cerebral hemodynamic response to moderate or severe maternal anemia. Am J Obstet Gynecol 2003; 188:794.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/25\">",
"      Sifakis S, Pharmakides G. Anemia in pregnancy. Ann N Y Acad Sci 2000; 900:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/26\">",
"      Brabin BJ, Hakimi M, Pelletier D. An analysis of anemia and pregnancy-related maternal mortality. J Nutr 2001; 131:604S.",
"     </a>",
"    </li>",
"    <li>",
"     www.who.int/making_pregnancy_safer/publications/en/ (accessed July 15, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/28\">",
"      Zeng L, Dibley MJ, Cheng Y, et al. Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial. BMJ 2008; 337:a2001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/29\">",
"      Christian P, Murray-Kolb LE, Khatry SK, et al. Prenatal micronutrient supplementation and intellectual and motor function in early school-aged children in Nepal. JAMA 2010; 304:2716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/30\">",
"      Giles C, Inglis TC. Thrombocytopenia and macrothrombocytosis in gestational hypertension. Br J Obstet Gynaecol 1981; 88:1115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/31\">",
"      Matthews JH, Benjamin S, Gill DS, Smith NA. Pregnancy-associated thrombocytopenia: definition, incidence and natural history. Acta Haematol 1990; 84:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/32\">",
"      Verdy E, Bessous V, Dreyfus M, et al. Longitudinal analysis of platelet count and volume in normal pregnancy. Thromb Haemost 1997; 77:806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/33\">",
"      Ahmed Y, van Iddekinge B, Paul C, et al. Retrospective analysis of platelet numbers and volumes in normal pregnancy and in pre-eclampsia. Br J Obstet Gynaecol 1993; 100:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/34\">",
"      Minakami H, Kuwata T, Sato I. Gestational thrombocytopenia: is it new? Am J Obstet Gynecol 1996; 175:1676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/35\">",
"      Saha P, Stott D, Atalla R. Haemostatic changes in the puerperium '6 weeks postpartum' (HIP Study) - implication for maternal thromboembolism. BJOG 2009; 116:1602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/36\">",
"      Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 1993; 329:1463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/37\">",
"      Rouse DJ, Owen J, Goldenberg RL. Routine maternal platelet count: an assessment of a technologically driven screening practice. Am J Obstet Gynecol 1998; 179:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/38\">",
"      George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/39\">",
"      KUVIN SF, BRECHER G. Differential neutrophil counts in pregnancy. N Engl J Med 1962; 266:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/40\">",
"      Molberg P, Johnson C, Brown TS. Leukocytosis in labor: what are its implications? Fam Pract Res J 1994; 14:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/41\">",
"      Acker DB, Johnson MP, Sachs BP, Friedman EA. The leukocyte count in labor. Am J Obstet Gynecol 1985; 153:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/42\">",
"      Siegel I, Gleicher N. Peripheral white blood cell alterations in early labor. Diagn Gynecol Obstet 1981; 3:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/43\">",
"      Fern&aacute;ndez-Su&aacute;rez A, Pascual VT, Gimenez MT, Hern&aacute;ndez JF. Immature granulocyte detection by the SE-9000 haematology analyser during pregnancy. Clin Lab Haematol 2003; 25:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/44\">",
"      Pramanik SS, Pramanik T, Mondal SC, Chanda R. Number, maturity and phagocytic activity of neutrophils in the three trimesters of pregnancy. East Mediterr Health J 2007; 13:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/45\">",
"      K&uuml;hnert M, Strohmeier R, Stegm&uuml;ller M, Halberstadt E. Changes in lymphocyte subsets during normal pregnancy. Eur J Obstet Gynecol Reprod Biol 1998; 76:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/46\">",
"      Paidas MJ, Ku DH, Arkel YS. Screening and management of inherited thrombophilias in the setting of adverse pregnancy outcome. Clin Perinatol 2004; 31:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/47\">",
"      Greer IA. Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology. Baillieres Clin Obstet Gynaecol 1997; 11:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/48\">",
"      Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999; 353:1258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/49\">",
"      Lindqvist P, Dahlb&auml;ck B, Mar&aacute;l K. Thrombotic risk during pregnancy: a population study. Obstet Gynecol 1999; 94:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/50\">",
"      Andersen BS, Steffensen FH, S&oslash;rensen HT, et al. The cumulative incidence of venous thromboembolism during pregnancy and puerperium--an 11 year Danish population-based study of 63,300 pregnancies. Acta Obstet Gynecol Scand 1998; 77:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/51\">",
"      Hellgren M, Blomb&auml;ck M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal condition. Gynecol Obstet Invest 1981; 12:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/52\">",
"      Stirling Y, Woolf L, North WR, et al. Haemostasis in normal pregnancy. Thromb Haemost 1984; 52:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/53\">",
"      Comp PC, Thurnau GR, Welsh J, Esmon CT. Functional and immunologic protein S levels are decreased during pregnancy. Blood 1986; 68:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/54\">",
"      Cumming AM, Tait RC, Fildes S, et al. Development of resistance to activated protein C during pregnancy. Br J Haematol 1995; 90:725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/55\">",
"      Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 2003; 16:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/56\">",
"      Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 2003; 29:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/57\">",
"      Esmon CT. Molecular events that control the protein C anticoagulant pathway. Thromb Haemost 1993; 70:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/58\">",
"      Ku DH, Arkel YS, Paidas MP, Lockwood CJ. Circulating levels of inflammatory cytokines (IL-1 beta and TNF-alpha), resistance to activated protein C, thrombin and fibrin generation in uncomplicated pregnancies. Thromb Haemost 2003; 90:1074.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/59\">",
"      Clark P, Brennand J, Conkie JA, et al. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998; 79:1166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/60\">",
"      Cerneca F, Ricci G, Simeone R, et al. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol 1997; 73:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/61\">",
"      Berge LN, Lyngmo V, Svensson B, Nord&oslash;y A. The bleeding time in women: an influence of the sex hormones? Acta Obstet Gynecol Scand 1993; 72:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21703/abstract/62\">",
"      Rymark P, Berntorp E, Nordsj&ouml; P, et al. Low-dose aspirin to pregnant women: single dose pharmacokinetics and influence of short term treatment on bleeding time. J Perinat Med 1994; 22:205.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 429 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-DEDEA7E9BD-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_12_21703=[""].join("\n");
var outline_f21_12_21703=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PLASMA VOLUME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      RED BLOOD CELLS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Anemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Iron requirements",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Diagnosis, prevention, and treatment of iron deficiency anemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Folate requirements",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PLATELET COUNT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Thrombocytopenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      WHITE BLOOD CELLS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      COAGULATION FACTORS AND INHIBITORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H878578652\">",
"      POSTPARTUM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/429\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/429|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/32/9742\" title=\"figure 1\">",
"      Blood volume in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/429|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/33/38424\" title=\"table 1\">",
"      Normal reference ranges in pregnant women",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29418?source=related_link\">",
"      Approach to the adult patient with anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26234?source=related_link\">",
"      Causes and diagnosis of anemia due to iron deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/61/5081?source=related_link\">",
"      Folic acid for prevention of neural tube defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/5/26714?source=related_link\">",
"      Inherited thrombophilias in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/44/28362?source=related_link\">",
"      Nutrition in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/56/38793?source=related_link\">",
"      Thrombocytopenia in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/62/25578?source=related_link\">",
"      Treatment of anemia due to iron deficiency",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_12_21704="Pectus excavatum: Treatment";
var content_f21_12_21704=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pectus excavatum: Treatment",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/12/21704/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/12/21704/contributors\">",
"     Oscar H Mayer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/12/21704/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/12/21704/contributors\">",
"     Gregory Redding, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/12/21704/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/12/21704/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/12/21704/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 5, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pectus excavatum (PE) is a deformity of the chest wall characterized by sternal depression, which typically begins over the midportion of the manubrium and progressing inward through the xiphoid process.",
"   </p>",
"   <p>",
"    The clinical significance of pectus excavatum depends on three issues:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Severity of the chest wall defect",
"     </li>",
"     <li>",
"      Cardiopulmonary morbidity",
"     </li>",
"     <li>",
"      Psychosocial impact of the defect and its appearance on the patient",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite decades of experience with surgical and nonsurgical treatment and efforts to quantify outcomes in each of these areas, the decision of when and how to treat pectus excavatum remains controversial. These issues are discussed in this topic review.",
"   </p>",
"   <p>",
"    The etiology, natural history, and evaluation of a child with PE are discussed in a separate topic review. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/41/18071?source=see_link\">",
"     \"Pectus excavatum: Etiology and evaluation\"",
"    </a>",
"    .) The diagnosis and treatment of pectus carinatum and other chest wall deformities are also reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/39/25207?source=see_link\">",
"     \"Pectus carinatum\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/58/24490?source=see_link\">",
"     \"Diseases of the chest wall\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical correction of pectus excavatum improves physical appearance in most patients and cardiorespiratory function in some, but the indications for intervention are not fully standardized.",
"   </p>",
"   <p>",
"    Variables measured as surgical outcomes include objective improvements in PE severity and cardiopulmonary function, and the patient's subjective report of symptoms and concerns about appearance.",
"   </p>",
"   <p>",
"    The evaluation of a patient with PE is discussed in a separate topic review. For patients with moderate or severe PE on visual inspection, a CT scan should be performed to determine the pectus severity index (PSI), which is ratio of the lateral diameter of the chest to the distance between the sternum and spine, at the point of maximal depression. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/41/18071?source=see_link&amp;anchor=H8#H8\">",
"     \"Pectus excavatum: Etiology and evaluation\", section on 'Evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We and others generally consider corrective surgery in patients with two or more of the following criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pectus index of &gt;3.25 (measured on CT scan)",
"     </li>",
"     <li>",
"      Cardiac compression, displacement, mitral valve prolapse, murmurs, or conduction abnormalities",
"     </li>",
"     <li>",
"      Pulmonary function testing showing restrictive abnormalities",
"     </li>",
"     <li>",
"      Failed previous repair of PE",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other factors supporting surgery in some cases are documented progression of the PE deformity with worsening of physiologic symptoms, or significant patient concern about appearance [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/1,4\">",
"     1,4",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     TIMING",
"    </span>",
"    &nbsp;&mdash;&nbsp;When surgical intervention to treat PE was first contemplated more than 60 years ago, experts advocated surgical intervention early in life, ideally before 20 months of age. Early intervention was advocated because PE was hypothesized to be caused by imbalance of muscular forces on the sternum, and could be treated by modifying the cartilage and bone structure and relationship of the sternum, costal cartilages, and ribs [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Moreover, surgery performed during or after adolescence had high morbidity and failure rates in that era [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/7\">",
"     7",
"    </a>",
"    ]. This led to the philosophy that \"prophylaxis is better than cure\" [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/6\">",
"     6",
"    </a>",
"    ]. However, it became clear that children undergoing early surgical intervention had a high risk for recurrence of PE during adolescence, and extensive resection of costal cartilage in young children also restricted chest wall growth in some cases [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/8\">",
"     8",
"    </a>",
"    ]. This experience has led to later timing of surgical intervention for PE.",
"   </p>",
"   <p>",
"    Currently, the general consensus is that the optimal time to correct a pectus defect is, at the earliest, eight years of age, and certainly before the end of adolescence. Children in this age range are young enough to have compliant costal cartilage that is amenable to remodeling, but old enough to reduce potential for recurrence during the pubertal growth spurt [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/9-12\">",
"     9-12",
"    </a>",
"    ]. This consensus is based on collective experience and published case series, but has not been established through organized clinical trials. It is possible that the ideal timing for surgical repair varies with the surgical approach, but this question has not yet been examined.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     TYPES OF SURGERY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Historical approaches",
"    </span>",
"    &nbsp;&mdash;&nbsp;Current surgical options to correct pectus excavatum have evolved from experience with historical approaches.",
"   </p>",
"   <p>",
"    During the 1920s, Sauerbruch resected both deformed ribs and cartilage, but this approach left a flail chest and had a 24 percent mortality rate [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/2,13\">",
"     2,13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    During the 1930s, Brown performed a more limited resection, removing abnormal cartilage, performing a sternal osteotomy and releasing the sternum from the inward pull of the diaphragm. Postoperatively, he used external traction to keep the repair in place. However, patients were prone to infection, presumably due to the external traction [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/13\">",
"     13",
"    </a>",
"    ]. The external traction was discarded in the 1940s; as a result, the PE often recurred postoperatively.",
"   </p>",
"   <p>",
"    During the 1940s, theories about abnormal diaphragmatic connections led to an even more limited surgical intervention in which the central tendon of the diaphragm and substernal ligament were released [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/14\">",
"     14",
"    </a>",
"    ]. The surgery was performed during infancy or early childhood. This approach was discarded because it was not effective. Furthermore, modern imaging and thoracoscopy have refuted the mechanistic theory underlying the approach [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Current approaches",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two surgical procedures are in active use today, with minor variations in technique:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Modified Ravitch procedure &mdash; The Ravitch procedure (referred to as the \"open procedure\" in some reports) is a modification of Brown's method, consisting of resection of the subperichondrial cartilage, a sternal osteotomy underneath the angle of the pectus excavatum, and temporary internal fixation to support the sternum (",
"      <a class=\"graphic graphic_figure graphicRef75569 \" href=\"UTD.htm?8/42/8871\">",
"       figure 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/2,13\">",
"       2,13",
"      </a>",
"      ]. The Ravitch procedure was first performed during the 1940s, and has been modified since then to improve internal stabilization of the sternum, maximize the quality of the correction, and minimize complications [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/10,15,16\">",
"       10,15,16",
"      </a>",
"      ]. Various forms of sternal fixation have been used for this procedure, including removable sternal fixation along the rib cage with a connecting strut through the sternum [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/16\">",
"       16",
"      </a>",
"      ], and a synthetic mesh placed under the sternum and attached to the rib cage laterally (",
"      <a class=\"graphic graphic_figure graphicRef75350 \" href=\"UTD.htm?35/32/36354\">",
"       figure 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Nuss procedure &mdash; The Nuss procedure (referred to as the \"minimally invasive\" or \"closed\" procedure in some reports) represents a dramatically different approach to PE repair. It corrects the pectus defect without cartilage resection by applying outward pressure to the sternum at the point of maximal inward deflection, using a custom-contoured steel bar (\"Nuss bar\"). The Nuss bar is placed in the pleural space, passed behind the sternum, rotated 180 degrees, then attached laterally to the outer edge of the rib cage (",
"      <a class=\"graphic graphic_figure graphicRef51937 \" href=\"UTD.htm?5/23/5492\">",
"       figure 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The Nuss procedure has also been modified to reduce the sternal stress by performing \"relaxing\" cartilage incisions [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/18\">",
"     18",
"    </a>",
"    ], to better stabilize the bar on the rib cage using lateral stabilizers [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/11,19\">",
"     11,19",
"    </a>",
"    ], and to correct longer and more complicated defects by using multiple bars [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/19-23\">",
"     19-23",
"    </a>",
"    ]. A &ldquo;morphology-tailored&rdquo; modification of the procedure has been used effectively, in which differently shaped bars are selected according to the morphology of the patient&rsquo;s defect [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Nuss bar is typically removed after about two years. There is no objective evidence to guide the timing of the bar removal. Some authors have suggested that measures of bone density, as a marker for skeletal maturation, might be a clinically useful predictor of success after bar removal [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/25\">",
"     25",
"    </a>",
"    ]. This approach has not been fully validated in an organized clinical trial.",
"   </p>",
"   <p>",
"    The relative benefits and risks of these approaches are discussed below. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Outcomes'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H11\">",
"     'Complications'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Other approaches",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sternal suction &mdash; A preliminary case series suggests that suction applied externally to the sternum can reduce the sternal depression by about 1 cm per month [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/26,27\">",
"       26,27",
"      </a>",
"      ]. The suction device is used for one or more hours daily for 12 to 15 months. Two case series suggest significant improvement in PE during the course of treatment, but outcomes after cessation of treatment have not been reported [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/26,27\">",
"       26,27",
"      </a>",
"      ]. The device has also been used as an adjunct to conventional surgical correction.",
"     </li>",
"     <li>",
"      Sternal magnet &mdash; The magnetic Mini-Mover procedure (3MP) has been designed to lift the sternum using magnetic attraction between a magnet attached to the sternum and another magnet on an external sternal brace [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/28\">",
"       28",
"      </a>",
"      ]. This approach is a paradigm shift in that it applies a small force over a long period of time, as opposed to a large force over a short period of time as applied in the Nuss procedure. The persistent gentle force allows the sternum to slowly remold [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/28,29\">",
"       28,29",
"      </a>",
"      ]. This contrasts with the large forces employed in the modified Ravitch and Nuss procedures, and potentially avoids the associated surgical trauma and pain. A pilot study examined the safety and efficacy of the 3MP over an 18 month treatment period, with an additional one year follow-up period after the 3MP was removed [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/29,30\">",
"       29,30",
"      </a>",
"      ]. There was no significant change in the pectus severity index (PSI) in the 10 study subjects, but there was a trend towards improvement in the PSI in prepubertal subjects under 14 years of age. There was one device failure, but no cardiac or other side effects.",
"     </li>",
"     <li>",
"      Prosthetic inserts &mdash; Some patients with PE but no significant symptoms have been treated with silicone prosthetic inserts, which improve the appearance of the chest without changing the sternal contour [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/31,32\">",
"       31,32",
"      </a>",
"      ]. Initial problems with migration of the inserts were addressed by coarsening the surface and perforating the prosthesis to promote attachment to native tissue [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/31\">",
"       31",
"      </a>",
"      ]. One group has reported perioperative problems with seroma in 31 percent of patients, all but one of which was treatable and temporary [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Physical therapy &mdash; Physical therapy interventions have been offered to patients with mild pectus excavatum who do not desire or are not candidates for surgical correction [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/33,34\">",
"       33,34",
"      </a>",
"      ]. Physical therapy strategies attempt to improve the interplay between respiratory muscles and chest wall by improving posture and increasing chest wall expansion, harkening back to some of the early hypotheses that suggested that PE is caused by abnormal muscle forces acting on the rib cage. The intervention includes exercises designed to strengthen the thoracic musculature and promote use of specific muscle groups during breathing and breath holding [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/33,34\">",
"       33,34",
"      </a>",
"      ]. Outcomes have been published only as scattered case reports, so the efficacy of this technique is unclear.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no large prospective studies comparing outcomes of the Nuss and Ravitch procedures. Currently, the surgical approach usually depends on the preferences of the surgeon and institution. Therefore, robust comparisons between the procedures will require a well-organized multicenter study, rather than the retrospective case series that are currently in the literature.",
"   </p>",
"   <p>",
"    Based on these indirect comparisons, outcomes of appearance, self-reported exercise capacity, and objective measures of cardiopulmonary function appear to be similar after the two procedures, as described below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Appearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients experience subjective improvement in self-image and appearance after either the modified Ravitch or Nuss procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/10,35,36\">",
"     10,35,36",
"    </a>",
"    ]. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A large series of adult and pediatric patients undergoing the modified Ravitch procedure at a single center reported that 94 percent of patients felt that their results were very good or excellent [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A large multicenter study of over 260 patients demonstrated that patient self-image concerns decreased from 68 to 6 percent in female patients, and from 40 to 4 percent in male patients, when measured two years after Nuss bar placement [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/1\">",
"       1",
"      </a>",
"      ]. In addition, 97 percent of patients liked the way their chest looked, 90 percent were happy they did surgery, and there was a significant decrease in overall parental concern.",
"     </li>",
"     <li>",
"      In his initial decade of experience in using the procedure, Nuss reported that 87 percent of patients had a normal chest appearance or mild residual pectus after surgery [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/13\">",
"       13",
"      </a>",
"      ]. However, the outcomes in adolescent patients tended to be worse than in younger children, perhaps because younger children have a more compliant chest wall. The outcomes were worse initially as the surgical technique was developed and refined, reflecting a learning curve associated with the new procedure.",
"     </li>",
"     <li>",
"      A retrospective series described self-reported outcomes among 43 patients who had either the Nuss or modified Ravitch procedure performed at a single institution [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/37\">",
"       37",
"      </a>",
"      ]. At the time of follow up (average 16.3 months postoperatively), patients who had the Nuss procedure were more satisfied with their appearance and reported less frequent chest pain or discomfort than those who had the modified Ravitch procedure. However, the differences were modest, and the lack of randomization in this and other studies precludes firm conclusions about the relative success of the procedures.",
"     </li>",
"     <li>",
"      In a series of 1170 patients at a single center, a &ldquo;morphology-tailored&rdquo; Nuss procedure was used [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/24\">",
"       24",
"      </a>",
"      ]. Patient-reported satisfaction was excellent in 93 percent and good in 6 percent. Complication rates were modest and decreased over time, as discussed below. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Complications'",
"      </a>",
"      below.) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Cardiopulmonary function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subjective improvement in exercise tolerance and subtle improvements in some objective measures of cardiopulmonary function have been reported after either the modified Ravitch or Nuss procedure.",
"   </p>",
"   <p>",
"    The effect of the modified Ravitch procedure on forced vital capacity (FVC) is variable. Among 66 patients undergoing the Nuss procedure at a median age of 19 years, FVC improved from 88 percent to 92 percent of predicted value (p&lt;0.001), while FEV1 improved from 83 to 88 percent predicted value (p&lt;0.01) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/38\">",
"     38",
"    </a>",
"    ]. However, the clinical significance of these small, albeit statistically significant, increases in lung function is questionable. Two smaller studies reported a decrease or no change in FVC [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. After the modified Ravitch procedure there is often a subjective improvement in exercise symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/10,35,39,40\">",
"     10,35,39,40",
"    </a>",
"    ]. Cardiac outcomes include an improvement in right ventricular filling [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/41\">",
"     41",
"    </a>",
"    ], stroke volume [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/39,40\">",
"     39,40",
"    </a>",
"    ], and shifting of the displaced heart back to midline [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/35\">",
"     35",
"    </a>",
"    ]. Improvement in oxygen pulse is detectable in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/40\">",
"     40",
"    </a>",
"    ]. Metaanalyses suggest borderline improvement in VO2max (maximum oxygen consumption) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/39,42\">",
"     39,42",
"    </a>",
"    ]. These findings suggest that the improvement in exercise tolerance may be related to improved cardiac function and not pulmonary function [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/41,43\">",
"     41,43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Following the Nuss procedure, pulmonary function outcomes are variable, and in some cases, there is a transient decrease in lung function after Nuss bar insertion, followed by a return to or improvement over preoperative values after Nuss bar removal [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/39,41,44,45\">",
"     39,41,44,45",
"    </a>",
"    ]. Most patients also report subjective improvement in exercise capacity [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. However, as with the modified Ravitch procedure, objective measures of exercise capacity (eg, VO2max) either do not change, or improve only slightly after surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/39,44,46\">",
"     39,44,46",
"    </a>",
"    ]. The cardiac outcomes are more consistently positive, with an increase in stroke volume and right ventricular filling [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/41\">",
"     41",
"    </a>",
"    ], and in electrocardiographic abnormalities, which are thought to be due to a relief of the preoperative cardiac compression [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The modified Ravitch and Nuss procedures have different types of complications, but the overall frequency and severity of complications is similar. Each procedure has been successfully modified to address some of these complications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Modified Ravitch procedure",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Secondary thoracic dystrophy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Perhaps the most concerning complication of the modified Ravitch procedure is the risk for developing a constricted thorax or secondary thoracic dystrophy (Acquired Jeune Syndrome). This is probably caused by excessive resection of the costal cartilage, including the growth centers, excessive traction on the perichondrium, or damage of the bone and cartilage growth centers [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/8,35,48,49\">",
"     8,35,48,49",
"    </a>",
"    ]. In this case, normal chest wall growth does not occur, and the thoracic cage restricts lung growth. In the initial series of 12 patients with thoracic dystrophy after PE repair, the mean forced vital capacity (FVC) was 33 to 55 percent of predicted, and the total lung capacity (TLC) 32 to 64 percent of predicted [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Risk factors for secondary thoracic dystrophy include surgery at an early age (&lt;4 years), resection of five or more costal cartilages, interruption of the growth center between the sternum and the second rib, and attachment of the perichondrial sheaths together behind the sternum [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/8,48\">",
"     8,48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    To reduce this risk, it has been recommended to delay pectus excavatum repair until at least until eight years of age, and to resect four or fewer cartilages [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/8\">",
"     8",
"    </a>",
"    ]. With these modifications, secondary thoracic dystrophy was not reported in more recent series [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Nuss procedure",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Postoperative pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several series suggest that patients undergoing the Nuss procedure have somewhat more postoperative pain than those undergoing the Ravitch procedure, and require more analgesia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/13,35,37,50,51\">",
"     13,35,37,50,51",
"    </a>",
"    ]. However, in a large series of patients undergoing the Nuss or Ravitch procedure, perioperative pain was managed equally effectively after either procedure, and postoperative pain resolved within one month in all patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One explanation for the additional postoperative pain after the Nuss procedure is that the act of forcing the sternum into a normal orientation puts a strain on the costal cartilage as well as stress on both the ribs and the sternum. The rib stress and cartilage strain can cause small rib and sternum fractures seen on ultrasound [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/53\">",
"     53",
"    </a>",
"    ] and nuclear medicine scans [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/54\">",
"     54",
"    </a>",
"    ]. The risk of fracture is related to age (with an increased risk in patients older than 9 to 10 years [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]), and also to the amount of sternal elevation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because of their increased need for analgesia, patients undergoing the Nuss procedure generally have slightly longer hospital stays than those undergoing the Ravitch procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/13,35,37,50,51\">",
"     13,35,37,50,51",
"    </a>",
"    ]. Some series report similar operative times for the two procedures; other series report somewhat shorter operative times for the Nuss procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Bar displacement",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common complication of the Nuss procedure is displacement of the bar, which was reported in between 2 and 27 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/55-57\">",
"     55-57",
"    </a>",
"    ]. In some cases, the bar is displaced by rotation (90 or 180 degree posteriorly), and in other cases, it is displaced laterally [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/56\">",
"     56",
"    </a>",
"    ]. Surgical experience and some technical improvements in stabilizer design have reduced the likelihood of Nuss bar displacement [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/11,13,55\">",
"     11,13,55",
"    </a>",
"    ]. In one series, bar displacement occurred in 15 percent of patients before stabilizers were used, and 5 percent of patients after implementation of wired stabilizers [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/58\">",
"     58",
"    </a>",
"    ]. When stabilization techniques are used, bar displacement within 30 days of the operation occur in 0.5 to 3 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/24,52,55\">",
"     24,52,55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Cardiac complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;There have been reports of cardiac perforation during the retrosternal dissection that is performed before passing the Nuss bar into the retrosternal space [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. To avoid this complication, some surgeons elevate the sternum with an external device to better expose the retrosternal space. Transesophageal echocardiography may also be used to ensure safe retrosternal dissection and placement of the Nuss bar.",
"   </p>",
"   <p>",
"    Postoperative pericarditis or pericardial effusions have been reported in 0.6 to 4 percent of cases, presumably due to the inadvertent entry of the pericardial space [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/22,55,58,61\">",
"     22,55,58,61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Pneumothorax",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinically significant pneumothorax has been reported in 1 to 7 percent of patients undergoing either the Nuss procedure or Ravitch procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/50,52,55,57,58,60\">",
"     50,52,55,57,58,60",
"    </a>",
"    ]. In one large series of patients undergoing the Nuss procedure at a single center, pneumothorax rates improved over time, dropping from 7.5 percent at the beginning of the series to 0.8 percent ten years later [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/24\">",
"     24",
"    </a>",
"    ]. The authors attributed the improvement to improved postoperative drainage (hemo-vac).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Recurrence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reported rates of recurrence of PE after the modified Ravitch procedure range from 2 to 20 percent. However, these historical statistics may not reflect current risks because of improvements in surgical technique and changes in patient selection and timing [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/2,62,63\">",
"     2,62,63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patient factors that appear to increase the risk for PE recurrence after the modified Ravitch procedure include Marfan syndrome and the patient's age at operation; patients who are either younger or older than the optimal age range have somewhat higher risk of recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/10,62,64\">",
"     10,62,64",
"    </a>",
"    ]. There also can be significant problems due to chondrodystrophy, which is felt to worsen chest wall compliance [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/65\">",
"     65",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Timing'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Surgical factors that increase the risk for recurrence include inadequate support for the sternum after cartilage resection, failure to reattach the pectoralis and abdominal muscles over the cartilage, disrupting the vascular supply of the sternum, and excision of the xiphoid process [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When PE recurs after the Nuss procedure, it is usually attributable to bar displacement, premature bar removal, insufficient number of bars, having the bars enter the thorax too lateral, or use of an excessively compliant bar [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/13,63,65\">",
"     13,63,65",
"    </a>",
"    ]. In a large series from a single center, only 0.6 percent of patients had minor recurrences after bar removal [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Bar displacement'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    For patients with recurrent PE after the modified Ravitch procedure, reoperation with the Nuss procedure is usually successful [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/50,63-65\">",
"     50,63-65",
"    </a>",
"    ]. Conversely, for patients with unsatisfactory results after a Nuss procedure, reoperation with a modified Ravitch procedure is often successful [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/63\">",
"     63",
"    </a>",
"    ]. A repeat Nuss procedure also has been used effectively in such patients: in one series of 93 subjects in which a Nuss procedure was performed to correct a failed repair of either the modified Ravitch, Leonard, or the Nuss procedure, outcomes were considered &ldquo;excellent&rdquo; (based on surgeon assessment) in 75 percent of patients with a prior Nuss procedure and in 63 percent of patients with a previous modified Ravitch procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21704/abstract/65\">",
"     65",
"    </a>",
"    ]. While these outcomes are promising, the outcomes are subjective and without any physiologic or functional correlate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     CHOICE OF SURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;As described above, comparison of the modified Ravitch and Nuss procedures is based on case series, and conclusions are limited by lack of randomization, evolution of surgical technique over time, and lack of standardized selection criteria. Based on this limited information, the outcomes of appearance, self-reported exercise capacity, and objective measures of cardiopulmonary function appear to be similar after the two procedures. The procedures have different types of complications, but the overall frequency and severity of complications appear to be similar.",
"   </p>",
"   <p>",
"    In the absence of organized trials comparing outcomes of the modified Ravitch and Nuss procedures, we suggest that the choice of procedure be based on the preference and experience of the surgeon and institution.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increasing evidence suggests that surgical intervention for pectus excavatum (PE) has benefits to psychologic function for many patients, but variable physiologic benefit. The indications, timing, and optimal approach for intervention are not fully standardized.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most patients with mild PE do not require surgical treatment. Such patients should be reevaluated regularly to determine if the deformity is progressing, particularly during periods of rapid growth. They may be offered physical therapy, but the benefit of this intervention is not established. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/41/18071?source=see_link\">",
"       \"Pectus excavatum: Etiology and evaluation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We suggest corrective surgery in patients with moderate or severe PE (pectus index &gt;3.25), significant cardiopulmonary symptoms, cardiac compression, patient concern about appearance,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      progression of the deformity over time (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For most patients with the above indications, we suggest performing surgical intervention between late childhood and mid-adolescence (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Current consensus is that this age range allows for cartilage remodeling while minimizing the risk of recurrence during the puberty. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Timing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Currently, surgical correction for PE is done with either the modified Ravitch procedure (open resection of the subperichondrial cartilage and sternal osteotomy, with placement of an internal stabilizing device), or the Nuss procedure (minimally invasive technique in which a curved bar is inserted to lift the sternum; the bar is removed about two years later). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Current approaches'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Outcomes for the modified Ravitch and Nuss procedures have not been directly compared in organized trials. Based on case series, overall success for both procedures is high, and outcomes of appearance, self-reported exercise capacity, and objective measures of cardiopulmonary function appear to be similar. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Outcomes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The modified Ravitch and Nuss procedures have different types of complications, but the overall frequency and severity of complications appear to be similar. Modifications of the devices and surgical techniques and surgeon experience have reduced the risk of complications and recurrence. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the absence of organized trials comparing outcomes and complications of the modified Ravitch and Nuss procedures, the choice of procedure should be based on the preference and experience of the surgeon and institution. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Choice of surgery'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/1\">",
"      Kelly RE Jr, Cash TF, Shamberger RC, et al. Surgical repair of pectus excavatum markedly improves body image and perceived ability for physical activity: multicenter study. Pediatrics 2008; 122:1218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/2\">",
"      Kelly RE Jr. Pectus excavatum: historical background, clinical picture, preoperative evaluation and criteria for operation. Semin Pediatr Surg 2008; 17:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/3\">",
"      Nuss D, Kelly RE Jr. Indications and technique of Nuss procedure for pectus excavatum. Thorac Surg Clin 2010; 20:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/4\">",
"      Frantz FW. Indications and guidelines for pectus excavatum repair. Curr Opin Pediatr 2011; 23:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/5\">",
"      BROWN AL, COOK O. Cardio-respiratory studies in pre- and post-operative funnel chest (pectus excavatum). Dis Chest 1951; 20:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/6\">",
"      Ravitch MM. The Operative Treatment of Pectus Excavatum. Ann Surg 1949; 129:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/7\">",
"      Ratner MR. 50 Years Ago in The Journal of Pediatrics: The relation of pectus excavatum to pectus carinatum: Classification of anterior chest wall deformities and the effect on treatment. J Pediatr 2008; 152:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/8\">",
"      Haller JA Jr, Colombani PM, Humphries CT, et al. Chest wall constriction after too extensive and too early operations for pectus excavatum. Ann Thorac Surg 1996; 61:1618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/9\">",
"      Colombani PM. Preoperative assessment of chest wall deformities. Semin Thorac Cardiovasc Surg 2009; 21:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/10\">",
"      Fonkalsrud EW. 912 open pectus excavatum repairs: changing trends, lessons learned: one surgeon's experience. World J Surg 2009; 33:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/11\">",
"      Hebra A. Minimally invasive repair of pectus excavatum. Semin Thorac Cardiovasc Surg 2009; 21:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/12\">",
"      Ishimaru T, Kitano Y, Uchida H, et al. Growth spurt-related recurrence after Nuss procedure. J Pediatr Surg 2009; 44:E13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/13\">",
"      Nuss D, Kelly RE Jr, Croitoru DP, Katz ME. A 10-year review of a minimally invasive technique for the correction of pectus excavatum. J Pediatr Surg 1998; 33:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/14\">",
"      Lester CW. The Surgical Treatment of Funnel Chest. Ann Surg 1946; 123:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/15\">",
"      Robicsek F, Hebra A. To Nuss or not to Nuss? Two opposing views. Semin Thorac Cardiovasc Surg 2009; 21:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/16\">",
"      Saxena AK. Pectus less invasive extrapleural repair (PLIER). J Plast Reconstr Aesthet Surg 2009; 62:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/17\">",
"      Robicsek F, Watts LT, Fokin AA. Surgical repair of pectus excavatum and carinatum. Semin Thorac Cardiovasc Surg 2009; 21:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/18\">",
"      Al-Assiri A, Kravarusic D, Wong V, et al. Operative innovation to the \"Nuss\" procedure for pectus excavatum: operative and functional effects. J Pediatr Surg 2009; 44:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/19\">",
"      Pilegaard HK, Licht PB. Routine use of minimally invasive surgery for pectus excavatum in adults. Ann Thorac Surg 2008; 86:952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/20\">",
"      Felts E, Jouve JL, Blondel B, et al. Child pectus excavatum: correction by minimally invasive surgery. Orthop Traumatol Surg Res 2009; 95:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/21\">",
"      Olbrecht VA, Abdullah F, Arnold MA, et al. Upper sternal depression following Lorenz bar repair of pectus excavatum. Pediatr Surg Int 2008; 24:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/22\">",
"      Park HJ, Lee SY, Lee CS, et al. The Nuss procedure for pectus excavatum: evolution of techniques and early results on 322 patients. Ann Thorac Surg 2004; 77:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/23\">",
"      Redlinger RE Jr, Rushing GD, Moskowitz AD, et al. Minimally invasive repair of pectus excavatum in patients with Marfan syndrome and marfanoid features. J Pediatr Surg 2010; 45:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/24\">",
"      Park HJ, Jeong JY, Jo WM, et al. Minimally invasive repair of pectus excavatum: a novel morphology-tailored, patient-specific approach. J Thorac Cardiovasc Surg 2010; 139:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/25\">",
"      Okawada M, Kawasaki S, Okazaki T, et al. Bone mineral density as a marker for the timing of pectus bar removal after Nuss procedure. Asian J Surg 2009; 32:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/26\">",
"      Schier F, Bahr M, Klobe E. The vacuum chest wall lifter: an innovative, nonsurgical addition to the management of pectus excavatum. J Pediatr Surg 2005; 40:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/27\">",
"      Haecker FM, Mayr J. The vacuum bell for treatment of pectus excavatum: an alternative to surgical correction? Eur J Cardiothorac Surg 2006; 29:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/28\">",
"      Harrison MR, Estefan-Ventura D, Fechter R, et al. Magnetic Mini-Mover Procedure for pectus excavatum: I. Development, design, and simulations for feasibility and safety. J Pediatr Surg 2007; 42:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/29\">",
"      Harrison MR, Curran PF, Jamshidi R, et al. Magnetic mini-mover procedure for pectus excavatum II: initial findings of a Food and Drug Administration-sponsored trial. J Pediatr Surg 2010; 45:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/30\">",
"      Harrison MR, Gonzales KD, Bratton BJ, et al. Magnetic mini-mover procedure for pectus excavatum III: safety and efficacy in a Food and Drug Administration-sponsored clinical trial. J Pediatr Surg 2012; 47:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/31\">",
"      Saour S, Shaaban H, McPhail J, McArthur P. Customised silicone prostheses for the reconstruction of chest wall defects: technique of manufacture and final outcome. J Plast Reconstr Aesthet Surg 2008; 61:1205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/32\">",
"      Snel BJ, Spronk CA, Werker PM, van der Lei B. Pectus excavatum reconstruction with silicone implants: long-term results and a review of the english-language literature. Ann Plast Surg 2009; 62:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/33\">",
"      Canavan PK, Cahalin L. Integrated physical therapy intervention for a person with pectus excavatum and bilateral shoulder pain: a single-case study. Arch Phys Med Rehabil 2008; 89:2195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/34\">",
"      Nuss D, Kelly RE Jr. Minimally invasive surgical correction of chest wall deformities in children (Nuss procedure). Adv Pediatr 2008; 55:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/35\">",
"      Fonkalsrud EW. Current management of pectus excavatum. World J Surg 2003; 27:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/36\">",
"      Krasopoulos G, Dusmet M, Ladas G, Goldstraw P. Nuss procedure improves the quality of life in young male adults with pectus excavatum deformity. Eur J Cardiothorac Surg 2006; 29:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/37\">",
"      Lam MW, Klassen AF, Montgomery CJ, et al. Quality-of-life outcomes after surgical correction of pectus excavatum: a comparison of the Ravitch and Nuss procedures. J Pediatr Surg 2008; 43:819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/38\">",
"      Kelly RE, Goretsky MJ, Obermeyer R, et al. Twenty-one years of experience with minimally invasive repair of pectus excavatum by the Nuss procedure in 1215 patients. Ann Surg 2010; 252:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/39\">",
"      Johnson JN, Hartman TK, Pianosi PT, Driscoll DJ. Cardiorespiratory function after operation for pectus excavatum. J Pediatr 2008; 153:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/40\">",
"      Quigley PM, Haller JA Jr, Jelus KL, et al. Cardiorespiratory function before and after corrective surgery in pectus excavatum. J Pediatr 1996; 128:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/41\">",
"      Sigalet DL, Montgomery M, Harder J. Cardiopulmonary effects of closed repair of pectus excavatum. J Pediatr Surg 2003; 38:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/42\">",
"      Malek MH, Berger DE, Housh TJ, et al. Cardiovascular function following surgical repair of pectus excavatum: a metaanalysis. Chest 2006; 130:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/43\">",
"      Fonkalsrud EW. Management of pectus chest deformities in female patients. Am J Surg 2004; 187:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/44\">",
"      Bawazir OA, Montgomery M, Harder J, Sigalet DL. Midterm evaluation of cardiopulmonary effects of closed repair for pectus excavatum. J Pediatr Surg 2005; 40:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/45\">",
"      Lawson ML, Mellins RB, Tabangin M, et al. Impact of pectus excavatum on pulmonary function before and after repair with the Nuss procedure. J Pediatr Surg 2005; 40:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/46\">",
"      Borowitz D, Cerny F, Zallen G, et al. Pulmonary function and exercise response in patients with pectus excavatum after Nuss repair. J Pediatr Surg 2003; 38:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/47\">",
"      Huang PM, Liu CM, Cheng YJ, et al. Evaluation of intraoperative cardiovascular responses to closed repair for pectus excavatum. Thorac Cardiovasc Surg 2008; 56:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/48\">",
"      Haller JA Jr. Severe chest wall construction from growth retardation after too extensive and too early (&lt; 4 years) pectus excavatum repair: an alert. Ann Thorac Surg 1995; 60:1857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/49\">",
"      Pretorius ES, Haller JA, Fishman EK. Spiral CT with 3D reconstruction in children requiring reoperation for failure of chest wall growth after pectus excavatum surgery. Preliminary observations. Clin Imaging 1998; 22:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/50\">",
"      Antonoff MB, Erickson AE, Hess DJ, et al. When patients choose: comparison of Nuss, Ravitch, and Leonard procedures for primary repair of pectus excavatum. J Pediatr Surg 2009; 44:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/51\">",
"      Molik KA, Engum SA, Rescorla FJ, et al. Pectus excavatum repair: experience with standard and minimal invasive techniques. J Pediatr Surg 2001; 36:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/52\">",
"      Kelly RE Jr, Shamberger RC, Mellins RB, et al. Prospective multicenter study of surgical correction of pectus excavatum: design, perioperative complications, pain, and baseline pulmonary function facilitated by internet-based data collection. J Am Coll Surg 2007; 205:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/53\">",
"      Zeng Q, Lai JY, Wang XM, et al. Costochondral changes in the chest wall after the Nuss procedure: ultrasonographic findings. J Pediatr Surg 2008; 43:2147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/54\">",
"      Ohno K, Morotomi Y, Harumoto K, et al. Preliminary study on the effects of bar placement on the thorax after the nuss procedure for pectus excavatum using bone scintigraphy. Eur J Pediatr Surg 2006; 16:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/55\">",
"      Castellani C, Schalamon J, Saxena AK, H&ouml;ellwarth ME. Early complications of the Nuss procedure for pectus excavatum: a prospective study. Pediatr Surg Int 2008; 24:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/56\">",
"      Hebra A, Swoveland B, Egbert M, et al. Outcome analysis of minimally invasive repair of pectus excavatum: review of 251 cases. J Pediatr Surg 2000; 35:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/57\">",
"      Protopapas AD, Athanasiou T. Peri-operative data on the Nuss procedure in children with pectus excavatum: independent survey of the first 20 years' data. J Cardiothorac Surg 2008; 3:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/58\">",
"      Croitoru DP, Kelly RE Jr, Goretsky MJ, et al. Experience and modification update for the minimally invasive Nuss technique for pectus excavatum repair in 303 patients. J Pediatr Surg 2002; 37:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/59\">",
"      Belcher E, Arora S, Samancilar O, Goldstraw P. Reducing cardiac injury during minimally invasive repair of pectus excavatum. Eur J Cardiothorac Surg 2008; 33:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/60\">",
"      Park HJ, Lee SY, Lee CS. Complications associated with the Nuss procedure: analysis of risk factors and suggested measures for prevention of complications. J Pediatr Surg 2004; 39:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/61\">",
"      Williams AM, Crabbe DC. Pectus deformities of the anterior chest wall. Paediatr Respir Rev 2003; 4:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/62\">",
"      Ellis DG, Snyder CL, Mann CM. The 're-do' chest wall deformity correction. J Pediatr Surg 1997; 32:1267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/63\">",
"      Antonoff MB, Saltzman DA, Hess DJ, Acton RD. Retrospective review of reoperative pectus excavatum repairs. J Pediatr Surg 2010; 45:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/64\">",
"      Croitoru DP, Kelly RE Jr, Goretsky MJ, et al. The minimally invasive Nuss technique for recurrent or failed pectus excavatum repair in 50 patients. J Pediatr Surg 2005; 40:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21704/abstract/65\">",
"      Redlinger RE Jr, Kelly RE Jr, Nuss D, et al. One hundred patients with recurrent pectus excavatum repaired via the minimally invasive Nuss technique--effective in most regardless of initial operative approach. J Pediatr Surg 2011; 46:1177.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6362 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-202.43.93.2-04D01F2D42-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_12_21704=[""].join("\n");
var outline_f21_12_21704=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      TIMING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      TYPES OF SURGERY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Historical approaches",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Current approaches",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Other approaches",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Appearance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Cardiopulmonary function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Modified Ravitch procedure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Secondary thoracic dystrophy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Nuss procedure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Postoperative pain",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Bar displacement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Cardiac complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Pneumothorax",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Recurrence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      CHOICE OF SURGERY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6362\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6362|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/42/8871\" title=\"figure 1\">",
"      Ravitch repair pectus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/32/36354\" title=\"figure 2\">",
"      Mesh support pectus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/23/5492\" title=\"figure 3\">",
"      Nuss repair pectus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/58/24490?source=related_link\">",
"      Diseases of the chest wall",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/39/25207?source=related_link\">",
"      Pectus carinatum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/41/18071?source=related_link\">",
"      Pectus excavatum: Etiology and evaluation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_12_21705="Pneumococcal vaccination in adults";
var content_f21_12_21705=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pneumococcal vaccination in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/12/21705/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/12/21705/contributors\">",
"     Elaine I Tuomanen, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/12/21705/contributors\">",
"     Patricia L Hibberd, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/12/21705/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/12/21705/contributors\">",
"     John G Bartlett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/12/21705/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/12/21705/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/12/21705/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 22, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/8/12422?source=see_link\">",
"     pneumococcal polysaccharide vaccine",
"    </a>",
"    , the first vaccine derived from a capsular polysaccharide, is an important landmark in medical history. The polysaccharide antigens were used to induce type-specific antibodies that enhanced opsonization, phagocytosis, and killing of pneumococci by phagocytic cells.",
"   </p>",
"   <p>",
"    First used in 1945, the tetravalent vaccine was not widely distributed, since its deployment coincided with the discovery of penicillin [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/1\">",
"     1",
"    </a>",
"    ]. The prevailing thought at that time was: Why worry about a disease so easily controlled by antibiotics? However, the high current prevalence of multiple antibiotic resistant strains and the appreciable morbidity and mortality associated with invasive infections make vaccination more attractive, particularly in patients at increased risk. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/5/81?source=see_link\">",
"     \"Resistance of Streptococcus pneumoniae to beta-lactam antibiotics\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/18/3369?source=see_link\">",
"     \"Resistance of Streptococcus pneumoniae to the fluoroquinolones, doxycycline, and trimethoprim-sulfamethoxazole\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19704?source=see_link\">",
"     \"Resistance of Streptococcus pneumoniae to the macrolides, azalides, lincosamines, and ketolides\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the 1970s, Dr. Robert Austrian championed the manufacture and distribution of a 14-valent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/8/12422?source=see_link\">",
"     pneumococcal polysaccharide vaccine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. This evolved in 1983 to a 23-valent formulation (PPSV23). A significant breakthrough impacting the burden of pneumococcal disease is the licensing of a protein conjugate heptavalent vaccine (PCV7) in February 2000. Since polysaccharides are not immunogenic in children under the age of two years, the protein conjugate vaccine is a major step forward in prevention in this high-risk age group. Surveillance after the introduction of PCV7 to the standard childhood immunization schedule has shown that the vaccine is effective in preventing invasive pneumococcal disease (IPD) and providing herd immunity (",
"    <a class=\"graphic graphic_figure graphicRef64834 \" href=\"UTD.htm?10/26/10658\">",
"     figure 1",
"    </a>",
"    ). The current formulation of the pneumococcal conjugate vaccine in the United States, PCV13, contains antigens from 13 pneumococcal antigens. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7402?source=see_link\">",
"     \"Pneumococcal (Streptococcus pneumoniae) conjugate vaccines in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/37/601?source=see_link\">",
"     \"Impact of universal infant immunization with pneumococcal (Streptococcus pneumoniae) conjugate vaccines in the United States\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among patients with pneumococcal infections, case-fatality rates are highest for pneumococcal meningitis (20 to 35 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/4-6\">",
"     4-6",
"    </a>",
"    ] and as many as one-half of survivors have persistent neurologic sequelae in the absence of early dexamethasone therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/6\">",
"     6",
"    </a>",
"    ]. The polysaccharide vaccine potentially could prevent approximately one-half of these deaths. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/29/7642?source=see_link\">",
"     \"Invasive pneumococcal (Streptococcus pneumoniae) infections and bacteremia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22810?source=see_link\">",
"     \"Initial therapy and prognosis of bacterial meningitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pneumococcal vaccination in adults will be reviewed here. Pneumococcal vaccination in children and in immunocompromised hosts is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7402?source=see_link\">",
"     \"Pneumococcal (Streptococcus pneumoniae) conjugate vaccines in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/38/13926?source=see_link\">",
"     \"Pneumococcal (Streptococcus pneumoniae) polysaccharide vaccines in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/48/23306?source=see_link&amp;anchor=H10#H10\">",
"     \"Immunizations in solid organ transplant candidates and recipients\", section on 'Pneumococcus'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/57/25498?source=see_link&amp;anchor=H10#H10\">",
"     \"Immunizations after hematopoietic cell transplantation\", section on 'Pneumococcus'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/37/30296?source=see_link&amp;anchor=H6#H6\">",
"     \"Immunizations in patients with cancer\", section on 'Pneumococcal vaccine'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/53/32602?source=see_link&amp;anchor=H23#H23\">",
"     \"Immunizations during pregnancy\", section on 'Pneumococcus'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37273?source=see_link\">",
"     \"Immunizations in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     POLYSACCHARIDE VACCINES",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are over 90 different capsular types of pneumococci, making it impossible from a manufacturing point of view to base a comprehensive vaccine on polysaccharide alone. Thus, vaccines representing a subgroup of highly prevalent types have been formulated.",
"   </p>",
"   <p>",
"    The currently available pneumococcal polysaccharide vaccines (Pneumovax 23, Pnu-Immune 23), include 23 purified capsular polysaccharide antigens (serotypes 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F). Twenty-five micrograms of each capsular polysaccharide antigen are dissolved in isotonic saline solution with phenol (0.25 percent) or thimerosal (0.01 percent) added as preservative; there is no adjuvant. These serotypes were chosen to represent 85 to 90 percent of the serotypes that cause invasive disease in the United States.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Efficacy",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H625089405\">",
"    <span class=\"h3\">",
"     Invasive pneumococcal disease, pneumonia, and mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary vaccination and revaccination with the 23-valent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/8/12422?source=see_link\">",
"     pneumococcal polysaccharide vaccine",
"    </a>",
"    (PPSV23) induce persistent functional antibody response in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Numerous studies and meta-analyses have shown that PPSV23 protects against invasive pneumococcal disease (IPD), such as bacteremia and meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/9-16\">",
"     9-16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, there are conflicting data regarding its efficacy for the prevention of pneumonia, with most studies not showing a reduction in either all-cause pneumonia or pneumococcal pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/11,15,17,18\">",
"     11,15,17,18",
"    </a>",
"    ], but a prospective cohort study showing a significant reduction in both outcomes in elderly adults [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/19\">",
"     19",
"    </a>",
"    ]. A randomized trial has also suggested that PPSV23 reduces the incidence of all-cause pneumonia and pneumococcal pneumonia in nursing home residents [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A 2008 meta-analysis by the Cochrane group that assessed the efficacy of PPSV23 for preventing pneumococcal infection in adults had the following findings [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/11\">",
"     11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Strong evidence of efficacy against IPD (odds ratio 0.26, 95% CI 0.15-0.46)",
"     </li>",
"     <li>",
"      Inconclusive evidence regarding efficacy against all-cause pneumonia",
"     </li>",
"     <li>",
"      No reductions in all-cause mortality",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, in a study of 3415 patients with CAP requiring hospitalization (published after the data were gathered for the meta-analysis described above), individuals who had been vaccinated against pneumococcus previously had a 40 percent lower rate of mortality or ICU admission compared with those who had not been vaccinated [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/21\">",
"     21",
"    </a>",
"    ]. In contrast, in a population-based cohort study of 2950 adults who were hospitalized with CAP and who were followed for five years, receipt of PPSV23 was not associated with a reduced risk of all-cause mortality or hospitalization [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Of note, a 2009 meta-analysis drew attention to the effect of the quality of the trials evaluating pneumococcal vaccine efficacy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/18\">",
"     18",
"    </a>",
"    ]. Trials of higher quality (defined by the authors as being either double blind or having adequate concealment of allocation) showed no benefit of any formulation of the polysaccharide pneumococcal vaccine (including the earlier 14-valent vaccine) for the prevention of pneumonia. However, there remains controversy about the authors' conclusions, which conflict with an earlier meta-analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/23-25\">",
"     23-25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While the 2009 meta-analysis has raised some important questions [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/18\">",
"     18",
"    </a>",
"    ], the majority of the literature suggests that the greatest benefit of pneumococcal vaccination appears to be the prevention of invasive pneumococcal disease. Based on this, pneumococcal vaccination with PPSV23 is still considered appropriate for patients in high-risk groups, including all adults &ge;65 years of age and adults with certain comorbidities (",
"    <a class=\"graphic graphic_table graphicRef86782 \" href=\"UTD.htm?11/48/12046\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Indications'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H625089275\">",
"    <span class=\"h3\">",
"     Stroke and myocardial infarction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pneumococcal vaccination does not reduce the risk of stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/26\">",
"     26",
"    </a>",
"    ]. There are conflicting data regarding the efficacy of pneumococcal vaccination for reducing the risk of acute myocardial infarction [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/26-28\">",
"     26-28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/29/7642?source=see_link\">",
"     \"Invasive pneumococcal (Streptococcus pneumoniae) infections and bacteremia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H573915\">",
"    <span class=\"h3\">",
"     Comorbidities",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H625089217\">",
"    <span class=\"h4\">",
"     COPD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with chronic obstructive pulmonary disease (COPD) have increased rates of hospitalization due to pneumococcal pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. There are conflicting data regarding the risk among patients with asthma. In a case-control study, patients with asthma were at increased risk for invasive pneumococcal disease [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/31\">",
"     31",
"    </a>",
"    ], although in a separate cohort study, they did not have increased rates of hospitalization for pneumococcal pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/4/13386?source=see_link&amp;anchor=H3#H3\">",
"     \"Pneumococcal pneumonia in adults\", section on 'Risk factors'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/29/7642?source=see_link&amp;anchor=H6#H6\">",
"     \"Invasive pneumococcal (Streptococcus pneumoniae) infections and bacteremia\", section on 'Risk factors for infection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Limited data assessing the impact of pneumococcal vaccination on patients with COPD have not shown a reduction in morbidity or mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/32\">",
"     32",
"    </a>",
"    ]. The effectiveness of pneumococcal vaccination in preventing pneumonia in patients with asthma is also not well established [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/29,33\">",
"     29,33",
"    </a>",
"    ]. Nevertheless, the United States Centers for Disease Control and Prevention recommends vaccination of individuals with either COPD or asthma since patients with COPD (and possibly those with asthma) are at increased risk for severe disease, it can be difficult to distinguish between these conditions, and the data are too limited to exclude a benefit of pneumococcal vaccination for either condition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H625089239\">",
"    <span class=\"h4\">",
"     Immunocompromised hosts",
"    </span>",
"    &nbsp;&mdash;&nbsp;The efficacy of pneumococcal vaccination in immunocompromised hosts is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/37/30296?source=see_link&amp;anchor=H6#H6\">",
"     \"Immunizations in patients with cancer\", section on 'Pneumococcal vaccine'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/48/23306?source=see_link&amp;anchor=H10#H10\">",
"     \"Immunizations in solid organ transplant candidates and recipients\", section on 'Pneumococcus'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/57/25498?source=see_link&amp;anchor=H10#H10\">",
"     \"Immunizations after hematopoietic cell transplantation\", section on 'Pneumococcus'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37273?source=see_link\">",
"     \"Immunizations in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2155317327\">",
"    <span class=\"h3\">",
"     Dual pneumococcal and influenza vaccination",
"    </span>",
"    &nbsp;&mdash;&nbsp;A cohort study has suggested that dual pneumococcal and influenza vaccination is superior to either vaccine alone for preventing complications in elderly adults with chronic illnesses [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/34\">",
"     34",
"    </a>",
"    ]. In adults &ge;65 years of age with chronic illnesses, dual vaccination with the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/8/12422?source=see_link\">",
"     pneumococcal polysaccharide vaccine",
"    </a>",
"    and the inactivated influenza vaccine resulted in lower rates of death (hazard ratio [HR] 0.65, 95% CI 0.55-0.77), pneumonia (HR 0.57, 95% CI 0.51-0.64), ischemic stroke (HR 0.67, 95% CI 0.54-0.83), and acute myocardial infarction (HR 0.52, 95% CI 0.38-0.71) compared with unvaccinated individuals. Dual vaccination also resulted in fewer coronary (HR 0.59, 95%CI, 0.44-0.79) and intensive care unit admissions (HR 0.45, 95% CI 0.22-0.94) compared with unvaccinated individuals. Since this was not a randomized trial, it is possible that the results might be biased, particularly since individuals who received both vaccines may also have other behaviors that result in better health.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CONJUGATE VACCINES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conjugate pneumococcal vaccines were developed to address the following issues:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Immunogenicity for children aged less than two years",
"     </li>",
"     <li>",
"      The desirability of achieving a booster effect upon reimmunization",
"     </li>",
"     <li>",
"      Eradication of noninvasive disease",
"     </li>",
"     <li>",
"      Elimination of the carrier state",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An answer to immunogenicity would be to include a protein in the antigen preparation, thereby generating a T cell-dependent memory response. Furthermore, choosing an antigen that is a virulence determinant on the mucosal surface might address the issue of interrupting noninvasive disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23143?source=see_link\">",
"     \"Microbiology and pathogenesis of Streptococcus pneumoniae\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In 2010, a 13-valent conjugate pneumococcal vaccine (PCV13) was approved by the US Food and Drug Administration (FDA) for use in children; it replaces the heptavalent conjugate pneumococcal vaccine (PCV7). In 2011, PCV13 was approved for use in adults &ge;50 years of age based upon safety and immunogenicity data; these data showed that PCV13 induced antibody responses that were either comparable to or higher than the responses induced by PPSV23 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. PCV13 appears to have a similar safety profile as PPSV23. Despite these data, it has",
"    <strong>",
"     not",
"    </strong>",
"    been recommended by the United States Advisory Committee on Immunization Practices (ACIP) for use in healthy adults; this decision was based upon the lack of available data demonstrating clinical efficacy against pneumococcal pneumonia in adults and the lack of data regarding the full impact of routine PCV13 vaccination in children on the incidence of pneumococcal disease in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/37\">",
"     37",
"    </a>",
"    ]. The first of these issues is expected to be addressed in a trial in the Netherlands comparing PCV13 to placebo in 85,000 adults &ge;65 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In 2012, the ACIP began recommending",
"    <strong>",
"     both",
"    </strong>",
"    PCV13 and PPSV23 for use in individuals aged 19 or older with immunocompromising conditions (eg, HIV infection, cancer, functional or anatomic asplenia, solid organ transplantation), cerebrospinal fluid leaks, cochlear implants, chronic renal insufficiency, or nephrotic syndrome (",
"    <a class=\"graphic graphic_table graphicRef86782 \" href=\"UTD.htm?11/48/12046\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/39\">",
"     39",
"    </a>",
"    ]. The evidence supporting the use of pneumococcal conjugate vaccination in high-risk adults comes from a randomized trial of the 7-valent pneumococcal conjugate vaccine (PCV7) in HIV-infected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/40,41\">",
"     40,41",
"    </a>",
"    ] (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37273?source=see_link\">",
"     \"Immunizations in HIV-infected patients\"",
"    </a>",
"    ). Recommendations for pneumococcal vaccination are presented below. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Indications'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In one study, vaccination of elderly adults with PCV7 appeared to elicit higher and potentially more effective levels of antipneumococcal antibodies than PPSV23 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/42\">",
"     42",
"    </a>",
"    ], although in another study this was only the case for three of seven serotypes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/43\">",
"     43",
"    </a>",
"    ]. Other studies have suggested that PCV13 elicits comparable or higher antibody responses and opsonophagocytic activity than PPSV23 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/37,44\">",
"     37,44",
"    </a>",
"    ]. In another study, PCV7 elicited an increase in serotype-specific memory B cell responses, whereas PPSV23 resulted in a decrease in memory B cell frequency, supporting the hypothesis that pneumococcal conjugate vaccines (but not polysaccharide vaccines) induce a T cell-dependent memory response [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Taken together, the data from various studies comparing pneumococcal conjugate vaccines with PPSV23 in adults suggest that the conjugate vaccines are at least as immunogenic as PPSV23 for the serotypes covered, but a clear and consistent benefit to the conjugate vaccines has not been demonstrated [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/46\">",
"     46",
"    </a>",
"    ]. Significant drawbacks of the conjugate vaccines compared with the polysaccharide vaccines include coverage of fewer pneumococcal serotypes, the appearance of replacement strains (ie, serotypes that are not covered by the vaccine), and higher cost [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/46\">",
"     46",
"    </a>",
"    ]. In addition, PCV13 use in adults might not provide additional benefits over its use in young children, since the herd effect has resulted in greater than a 90 percent decline in pneumococcal disease due to vaccine serotypes in older children and adults [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/25,47\">",
"     25,47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A cost-effectiveness analysis has suggested that the use of PCV13 of adults using the existing indications would be more cost-effective than PPSV23 provided that the effectiveness of PCV13 at preventing nonbacteremic pneumococcal pneumonia is high ($28,900 versus $34,600 per quality-adjusted-life-year [QALY] gained, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/48\">",
"     48",
"    </a>",
"    ]. However, if PPV13 has low effectiveness at preventing nonbacteremic pneumococcal pneumonia, then PPSV23 is likely to be more cost-effective. This study has also suggested that although the use of PCV13 in adults at age 50 and 65 would be more costly ($45,100 per QALY gained) than if it were administered according to the existing indications, it would be favored if willingness-to-pay thresholds were &gt;$50,000 per QALY. The rationale for administering the vaccine at ages 50 and 65 is that vaccination of all individuals age 50 or older would likely lead to increased vaccination rates among those with comorbidities, such as smoking. Important limitations of this study are that it is difficult to estimate the effectiveness of PCV13 at preventing nonbacteremic pneumococcal pneumonia and at estimating the role that PCV13 would play in reducing nasopharyngeal colonization with vaccine serotypes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/49\">",
"     49",
"    </a>",
"    ]. Reduction in nasopharyngeal colonization is likely important for reducing pneumococcal pneumonia, but the herd effect caused by PCV13 vaccination of young children may be sufficient for reducing colonization and pneumonia in adults.",
"   </p>",
"   <p>",
"    Pneumococcal vaccination in immunocompromised hosts is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/37/30296?source=see_link\">",
"     \"Immunizations in patients with cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/48/23306?source=see_link&amp;anchor=H10#H10\">",
"     \"Immunizations in solid organ transplant candidates and recipients\", section on 'Pneumococcus'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/57/25498?source=see_link&amp;anchor=H10#H10\">",
"     \"Immunizations after hematopoietic cell transplantation\", section on 'Pneumococcus'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37273?source=see_link\">",
"     \"Immunizations in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The use of pneumococcal conjugate vaccines in children is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7402?source=see_link\">",
"     \"Pneumococcal (Streptococcus pneumoniae) conjugate vaccines in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/37/601?source=see_link\">",
"     \"Impact of universal infant immunization with pneumococcal (Streptococcus pneumoniae) conjugate vaccines in the United States\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2155316754\">",
"    <span class=\"h1\">",
"     POLYSACCHARIDE PLUS CONJUGATE VACCINES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the limitations in efficacy of the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/8/12422?source=see_link\">",
"     pneumococcal polysaccharide vaccine",
"    </a>",
"    (PPSV23), an important question is whether giving both PPSV23 and a conjugate pneumococcal vaccine to adults at high risk of invasive pneumococcal disease could provide additional benefit over PPSV23 alone. Several trials have addressed this question in various adult age groups and populations, but there appears to be no improvement in immunogenicity to using a prime-boost regimen of PPSV23 plus the heptavalent conjugate pneumococcal vaccine (PCV7):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one trial, adults who had recovered from pneumococcal pneumonia were given PPSV23 followed by PCV six months later, or vice versa [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/50\">",
"       50",
"      </a>",
"      ]. The following findings were noted:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Following the first injection, both PPSV23 and PCV7 stimulated similar IgG levels and opsonophagocytic killing activity (OPK). However, six months later, IgG levels returned to baseline in those who received PPSV23, whereas they remained modestly elevated in those who received PCV.",
"     </li>",
"     <li>",
"      Those who received PPSV23 followed by PCV7 had modest increases in IgG levels that failed to reach the peaks achieved after PPSV23 alone.",
"     </li>",
"     <li>",
"      Those who received PCV7 followed by PPSV23 had dramatic increases in IgG and OPK at four to eight weeks, but by six months these levels approached baseline levels.",
"      <br/>",
"      <br/>",
"      Thus, administering PPSV23 and PCV7 in a prime-boost regimen does not appear to provide long-lasting immunity against the pneumococcus.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In an open-label randomized trial of adults between 50 and 80 years of age, a prime-boost regimen of PCV7 followed by either PCV7 or PPSV23 six months later did not enhance the antibody response compared with a single dose of either vaccine formulation [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/43\">",
"       43",
"      </a>",
"      ]. Furthermore, any boost in immunogenicity by PCV7 would likely be limited to the serotypes in that formulation and not the additional serotypes in PPSV23.",
"     </li>",
"     <li>",
"      In another open-label randomized trial of adults between 50 and 70 years of age, a prime-boost regimen that included a two-dose series of PCV7 and a single dose of PPSV23 given six months apart in one of three combinations did not result in improved immunogenicity compared with a single dose of PCV7 [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/51\">",
"       51",
"      </a>",
"      ]. In addition, administration of PPSV23 prior to PCV7 resulted in attenuated antibody concentrations compared with PCV7 alone. &nbsp;",
"     </li>",
"     <li>",
"      In another trial, Alaskan Native adults between the ages of 55 and 70 were randomly assigned to receive PPSV23 alone, PCV7 followed two months later by PPSV23, or PCV7 followed six months later by PPSV23 [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/52\">",
"       52",
"      </a>",
"      ]. Neither geometric mean IgG concentrations nor median OPK titers against four serotypes included in both vaccines differed between the group that received PPSV23 alone and the groups that received PCV7 followed by PPSV23. Thus, the sequential use of PCV7 followed by PPSV23 provided no benefit over PPSV23 alone.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     INVESTIGATIONAL APPROACHES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hallmark of pneumococci is their ease of natural DNA transformation as evidenced by the diversity and rapidity of spread of antibiotic resistance. A strain can enter a day care center as one serotype and acquire another serotype capsule within just a few days [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/53\">",
"     53",
"    </a>",
"    ]. The molecular flexibility in the capsular locus is based upon its modular gene structure [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/54\">",
"     54",
"    </a>",
"    ]. There is no known physiologic mechanism that would limit capsular exchangeability. Under antibody selective pressure, it would be expected that pneumococci would quickly evolve to circumvent vaccines that contain a limited number of serotypes. Thus, developing vaccines that use highly conserved pneumococcal proteins (eg, pneumolysin, surface protein A) should be a research priority; several such vaccines are in development [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 23-valent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/8/12422?source=see_link\">",
"     pneumococcal polysaccharide vaccine",
"    </a>",
"    (PPSV23) has been recommended for many years in the United States for all adults &ge;65 years of age and in younger patients with a number of conditions that increase the risk of invasive pneumococcal disease. In 2012, the United States Advisory Committee on Immunization Practices (ACIP) began recommending",
"    <strong>",
"     both",
"    </strong>",
"    PPSV23 and the 13-valent conjugate pneumococcal vaccine (PCV13) for individuals aged 19 or older with immunocompromising conditions (eg, HIV infection, cancer, functional or anatomic asplenia, solid organ transplantation), cerebrospinal fluid leaks, cochlear implants, chronic renal insufficiency, or nephrotic syndrome (",
"    <a class=\"graphic graphic_table graphicRef86782 \" href=\"UTD.htm?11/48/12046\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In accordance with the ACIP, we recommend that individuals who meet the criteria described above receive PCV13 in addition to PPSV23 according to the following schedule (",
"    <a class=\"graphic graphic_table graphicRef86782 \" href=\"UTD.htm?11/48/12046\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/39\">",
"     39",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients who have not previously received either PCV13 or PPSV23, a single dose of PCV13 should be given, followed by a dose of PPSV23 at least eight weeks later.",
"     </li>",
"     <li>",
"      For patients who have previously received one or more doses of PPSV23, a single dose of PCV13 should be given one or more years after the last PPSV23 dose was received.",
"     </li>",
"     <li>",
"      For patients who require additional doses of PPSV23, the first such dose should be given no sooner than eight weeks after PCV13 and at least five years after the most recent dose of PPSV23.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although PCV13 was approved by the United States Food and Drug Administration for use in adults &ge;50 years of age in December 2011, it has",
"    <strong>",
"     not",
"    </strong>",
"    been recommended by the ACIP for healthy adults [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Starting in 2009, the ACIP began recommending that cigarette smoking and asthma be added as indications for vaccination with PPSV23 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/55\">",
"     55",
"    </a>",
"    ]. Guidance regarding smoking cessation therapies should be offered along with the pneumococcal vaccine [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/30,56\">",
"     30,56",
"    </a>",
"    ]. The strength of the recommendation for vaccination is greatest for patients at increased risk for bacteremia, such as smokers, people of African descent, asthmatics, and HIV-infected individuals. Adults who have been diagnosed with invasive pneumococcal disease should also be vaccinated because infection with one serotype does not necessarily provide protection against other serotypes.",
"   </p>",
"   <p>",
"    Despite these indications for vaccination, in 2005, a median of only 66 percent (range 28 to 72 percent) of patients &ge;65 years of age in the United States had been vaccinated [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/57\">",
"     57",
"    </a>",
"    ]. These estimates represent an improvement from the 34 percent rate of ever being vaccinated in 1995 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/58\">",
"     58",
"    </a>",
"    ]. In the 1995 report, the rate of ever being vaccinated in younger patients at high risk was only about 12 percent between the ages of 18 and 49 and 20 percent between the ages of 50 and 64.",
"   </p>",
"   <p>",
"    A cost-effectiveness analysis published in 2003 suggested that vaccination of all adults over the age of 50 years is cost-effective, especially for African Americans [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/59\">",
"     59",
"    </a>",
"    ]. An accompanying editorial advocated reconsideration of the adult immunization recommendations, although such a policy change would leave unclear when to reimmunize those receiving the vaccine at the younger ages [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/60\">",
"     60",
"    </a>",
"    ]. However, the apparent lack of reduction in either all-cause pneumonia or mortality, as noted in one meta-analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/11\">",
"     11",
"    </a>",
"    ], raises questions about the utility of vaccination of healthy adults between the ages of 50 and 64.",
"   </p>",
"   <p>",
"    Investigators used the Active Bacterial Core (ABC) surveillance-Emerging Infections Program Network to determine the proportion of invasive pneumococcal disease (IPD) that might be prevented if persons with vaccine indications had been vaccinated and to evaluate potential new indications [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/61\">",
"     61",
"    </a>",
"    ]. From 2001 to 2003, 1878 IPD case patients were identified, 1558 (83 percent) had at least one current vaccine indication; only 590 (38 percent) were vaccinated. Adherence to existing vaccine recommendations would have prevented 21 percent of all cases. The proportion of additional cases preventable by the following new indications were:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Lowering universal vaccination age to 50 years &ndash; 5 to 7 percent",
"     </li>",
"     <li>",
"      Current smoking &ndash; 1.5 to 2.5 percent",
"     </li>",
"     <li>",
"      Former smoking &ndash; 0.4 to 0.7 percent",
"     </li>",
"     <li>",
"      Black race &ndash; 1.0 to 1.4 percent",
"     </li>",
"     <li>",
"      Asthma &ndash; 0.3 to 0.4 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This study suggests that increasing vaccine coverage rates among persons with a current indication could prevent more cases than expanding existing indications. However, of the potential new indications studied, lowering the recommended age for universal vaccination to 50 years appears to be the most consequential strategy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     VACCINE ADMINISTRATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both pneumococcal vaccines are administered intramuscularly as a 0.5 mL dose. Both may be administered concurrently with other vaccines, such as the influenza vaccine, but at a separate site [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/62\">",
"     62",
"    </a>",
"    ]. Intradermal administration can cause severe local reactions and is inappropriate.",
"   </p>",
"   <p>",
"    Successful vaccination is indicated by an antigen-specific antibody response of at least twofold in serotype-specific antibody within two to three weeks; the responses may not be consistent among all serotypes in either vaccine. However, although important for epidemiologic studies, antibody determinations after vaccination are rarely performed in individual patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/48/24328?source=see_link&amp;anchor=H21#H21\">",
"     \"Assessing the immunologic response to vaccination\", section on 'Response to pneumococcal polysaccharides'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The serum concentrations of antibodies that correlate with protection against pneumococcal disease have not been clearly defined. The antibody concentrations to most pneumococcal vaccine antigens remain elevated for at least five years in healthy adults. In some individuals, antibody concentrations decrease to prevaccination levels by 10 years [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/63\">",
"     63",
"    </a>",
"    ]. Despite these observations, efficacy did not decline at nine or more years after vaccination in a report from the CDC's pneumococcal surveillance system [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H573510\">",
"    <span class=\"h2\">",
"     Revaccination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The United States Advisory Committee on Immunization Practices does not recommend routine revaccination of immunocompetent adults because data on the safety and effectiveness of additional doses are insufficient. However, a study in an Alaskan Native population found no difference in the risk of adverse events following &ge;3 doses of PPSV23, compared with one or two doses [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/64\">",
"     64",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Complications'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A single revaccination with PPSV23 is recommended in adults &ge;65 years of age if they were vaccinated more than five years previously at a time when they were less than 65 years of age, as well as in immunocompromised patients and individuals with functional or anatomic asplenia five years or more after the first dose (",
"    <a class=\"graphic graphic_table graphicRef86782 \" href=\"UTD.htm?11/48/12046\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common adverse reactions are injection site pain or tenderness (in 60 percent), swelling or induration (in 20 percent), and erythema (in 16 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/65\">",
"     65",
"    </a>",
"    ]. These reactions usually persist for less than 48 hours. Moderate systemic reactions (eg, fever and myalgias) and more severe local reactions (eg, local induration) are rare. The experience with PCV13 is similar [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/35,36\">",
"     35,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Revaccination after intervals of four years or more is not associated with an increased incidence of adverse side effects from PPSV23. This was illustrated in a retrospective review of medical records for health care facilities that serve the Alaskan Native population [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/64\">",
"     64",
"    </a>",
"    ]. Adverse events following vaccination occurred in 1 of 179 (0.6 percent) persons who had received &ge;3 doses compared with 4 of 181 (2.8 percent) who received one or two doses.",
"   </p>",
"   <p>",
"    As mentioned above, concurrent administration of the pneumococcal and influenza vaccine is safe and does not alter their effectiveness [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21705/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Healthcare providers should report suspected adverse events to the Vaccine Adverse Event Reporting System (VAERS) by calling (800) 822-7967, a 24-hour, toll-free telephone number.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/4/23619?source=see_link\">",
"       \"Patient information: Vaccines for adults (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/48/12035?source=see_link\">",
"       \"Patient information: Vaccines (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?13/57/14225?source=see_link\">",
"       \"Patient information: Pneumonia prevention (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H256255\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/8/12422?source=see_link\">",
"       pneumococcal polysaccharide vaccine",
"      </a>",
"      (Pneumovax 23, Pnu-Immune; PPSV23) includes 23 purified capsular polysaccharide antigens (serotypes 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F). These serotypes were chosen to represent 85 to 90 percent of the serotypes that cause invasive disease in the United States. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Polysaccharide vaccines'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Numerous studies and meta-analyses have shown that PPSV23 protects against invasive pneumococcal disease, such as bacteremia and meningitis. However, there are conflicting data regarding its efficacy for the prevention of pneumonia. In addition, there are conflicting data regarding its effect on mortality. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Efficacy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend PPSV23 for all adults &ge;65 years of age and in younger patients with a number of conditions that increase the risk of invasive pneumococcal disease. The indications for vaccination with PPSV23 are reviewed in the following Table (",
"      <a class=\"graphic graphic_table graphicRef86782 \" href=\"UTD.htm?11/48/12046\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      PPSV23 is administered intramuscularly as a 0.5 mL dose. It may be administered concurrently with other vaccines, such as the influenza vaccine, but at a separate site. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Vaccine administration'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A single revaccination with PPSV23 is recommended in adults &ge;65 years of age if they were vaccinated more than five years previously at a time when they were less than 65 years of age, and in immunocompromised patients, five years or more after the first dose. (See",
"      <a class=\"local\" href=\"#H573510\">",
"       'Revaccination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Approximately one-third of persons who receive PPSV23 develop mild, local side effects (eg, pain at the injection site, erythema, and swelling). These reactions usually persist for less than 48 hours. Moderate systemic reactions (eg, fever and myalgias) and more severe local reactions (eg, local induration) are rare. The experience with the 13-valent pneumococcal conjugate vaccine (PCV13) is similar. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In 2011, PCV13 was approved by the US Food and Drug Administration (FDA) for use in adults &ge;50 years of age based upon safety and immunogenicity data, but it has not been recommended by the United States Advisory Committee on Immunization Practices (ACIP) for use in healthy adults. We do not recommend PCV13 for healthy adults. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Conjugate vaccines'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In 2012, the ACIP began recommending",
"      <strong>",
"       both",
"      </strong>",
"      PCV13 and PPSV23 for individuals aged 19 or older with immunocompromising conditions (eg, HIV infection, cancer, functional or anatomic asplenia, solid organ transplantation), cerebrospinal fluid leaks, cochlear implants, chronic renal insufficiency, or nephrotic syndrome (",
"      <a class=\"graphic graphic_table graphicRef86782 \" href=\"UTD.htm?11/48/12046\">",
"       table 1",
"      </a>",
"      ). The schedule for administering these vaccines is discussed above. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/1\">",
"      Macleod CM, Hodges RG, Heidelberger M, Bernhard WG. PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES. J Exp Med 1945; 82:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/2\">",
"      Austrian R, Douglas RM, Schiffman G, et al. Prevention of pneumococcal pneumonia by vaccination. Trans Assoc Am Physicians 1976; 89:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/3\">",
"      Klein JO, Plotkin SA. Robert Austrian: 1917-2007. Clin Infect Dis. 2007; 45:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/4\">",
"      Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med 1997; 337:970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/5\">",
"      Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993; 328:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/6\">",
"      de Gans J, van de Beek D, European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002; 347:1549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/7\">",
"      Musher DM, Manof SB, Liss C, et al. Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults. J Infect Dis 2010; 201:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/8\">",
"      Manoff SB, Liss C, Caulfield MJ, et al. Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 &gt; or = years. J Infect Dis 2010; 201:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/9\">",
"      Butler JC, Breiman RF, Campbell JF, et al. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA 1993; 270:1826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/10\">",
"      Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991; 325:1453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/11\">",
"      Moberley SA, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008; :CD000422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/12\">",
"      Jackson LA, Neuzil KM, Yu O, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003; 348:1747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/13\">",
"      Dominguez A, Salleras L, Fedson DS, et al. Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain: a case-control study. Clin Infect Dis 2005; 40:1250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/14\">",
"      Musher DM, Rueda-Jaimes AM, Graviss EA, Rodriguez-Barradas MC. Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia. Clin Infect Dis 2006; 43:1004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/15\">",
"      Jackson LA, Janoff EN. Pneumococcal vaccination of elderly adults: new paradigms for protection. Clin Infect Dis 2008; 47:1328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/16\">",
"      Grabenstein JD. Effectiveness and serotype coverage: key criteria for pneumococcal vaccines for adults. Clin Infect Dis 2012; 55:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/17\">",
"      Ortqvist A, Hedlund J, Burman LA, et al. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group. Lancet 1998; 351:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/18\">",
"      Huss A, Scott P, Stuck AE, et al. Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ 2009; 180:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/19\">",
"      Vila-C&oacute;rcoles A, Ochoa-Gondar O, Hospital I, et al. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study. Clin Infect Dis 2006; 43:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/20\">",
"      Maruyama T, Taguchi O, Niederman MS, et al. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. BMJ 2010; 340:c1004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/21\">",
"      Johnstone J, Marrie TJ, Eurich DT, Majumdar SR. Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia. Arch Intern Med 2007; 167:1938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/22\">",
"      Johnstone J, Eurich DT, Minhas JK, et al. Impact of the pneumococcal vaccine on long-term morbidity and mortality of adults at high risk for pneumonia. Clin Infect Dis 2010; 51:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/23\">",
"      Andrews R, Moberley SA. The controversy over the efficacy of pneumococcal vaccine. CMAJ 2009; 180:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/24\">",
"      Jefferson T. Pneumococcal vaccines: confronting the confounders. Lancet 2009; 373:2008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/25\">",
"      Musher DM. Editorial commentary: should 13-valent protein-conjugate pneumococcal vaccine be used routinely in adults? Clin Infect Dis 2012; 55:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/26\">",
"      Tseng HF, Slezak JM, Quinn VP, et al. Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men. JAMA 2010; 303:1699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/27\">",
"      Lamontagne F, Garant MP, Carvalho JC, et al. Pneumococcal vaccination and risk of myocardial infarction. CMAJ 2008; 179:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/28\">",
"      Madjid M, Musher DM. Preventing myocardial infarction with vaccination: myths and realities. JAMA 2010; 303:1751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/29\">",
"      Lee TA, Weaver FM, Weiss KB. Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma. J Gen Intern Med 2007; 22:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/30\">",
"      Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Wkly Rep 2010; 59:1102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/31\">",
"      Talbot TR, Hartert TV, Mitchel E, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med 2005; 352:2082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/32\">",
"      Granger R, Walters J, Poole PJ, et al. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; :CD001390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/33\">",
"      Sheikh A, Alves B, Dhami S. Pneumococcal vaccine for asthma. Cochrane Database Syst Rev 2002; :CD002165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/34\">",
"      Hung IF, Leung AY, Chu DW, et al. Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study. Clin Infect Dis 2010; 51:1007.",
"     </a>",
"    </li>",
"    <li>",
"     FDA expands use of Prevnar 13 vaccine for people ages 50 and older. file://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm285431.htm (Accessed on January 03, 2012).",
"    </li>",
"    <li>",
"     Prevnar 13 - Highlights of prescribing information. file://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM201669.pdf (Accessed on January 03, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/37\">",
"      Centers for Disease Control and Prevention (CDC). Licensure of 13-valent pneumococcal conjugate vaccine for adults aged 50 years and older. MMWR Morb Mortal Wkly Rep 2012; 61:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/38\">",
"      Hak E, Grobbee DE, Sanders EA, et al. Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults. Neth J Med 2008; 66:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/39\">",
"      Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012; 61:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/40\">",
"      French N, Gordon SB, Mwalukomo T, et al. A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults. N Engl J Med 2010; 362:812.",
"     </a>",
"    </li>",
"    <li>",
"     Advisory Committee on Immunization Practices. Summary Report, February 22-23, 2012. file://www.cdc.gov/vaccines/recs/acip/downloads/min-feb12.pdf (Accessed on June 25, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/42\">",
"      de Roux A, Schm&ouml;le-Thoma B, Schm&ouml;ele-Thoma B, et al. Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis 2008; 46:1015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/43\">",
"      Goldblatt D, Southern J, Andrews N, et al. The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50-80 years. Clin Infect Dis 2009; 49:1318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/44\">",
"      Paradiso PR. Pneumococcal conjugate vaccine for adults: a new paradigm. Clin Infect Dis 2012; 55:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/45\">",
"      Clutterbuck EA, Lazarus R, Yu LM, et al. Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells. J Infect Dis 2012; 205:1408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/46\">",
"      Musher DM, Sampath R, Rodriguez-Barradas MC. The potential role for protein-conjugate pneumococcal vaccine in adults: what is the supporting evidence? Clin Infect Dis 2011; 52:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/47\">",
"      Pilishvili T, Lexau C, Farley MM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010; 201:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/48\">",
"      Smith KJ, Wateska AR, Nowalk MP, et al. Cost-effectiveness of adult vaccination strategies using pneumococcal conjugate vaccine compared with pneumococcal polysaccharide vaccine. JAMA 2012; 307:804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/49\">",
"      Shapiro ED. Prevention of pneumococcal infection with vaccines: an evolving story. JAMA 2012; 307:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/50\">",
"      Musher DM, Rueda AM, Nahm MH, et al. Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia. J Infect Dis 2008; 198:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/51\">",
"      Lazarus R, Clutterbuck E, Yu LM, et al. A randomized study comparing combined pneumococcal conjugate and polysaccharide vaccination schedules in adults. Clin Infect Dis 2011; 52:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/52\">",
"      Miernyk KM, Butler JC, Bulkow LR, et al. Immunogenicity and reactogenicity of pneumococcal polysaccharide and conjugate vaccines in alaska native adults 55-70 years of age. Clin Infect Dis 2009; 49:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/53\">",
"      Nesin M, Ramirez M, Tomasz A. Capsular transformation of a multidrug-resistant Streptococcus pneumoniae in vivo. J Infect Dis 1998; 177:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/54\">",
"      Caimano MJ, Hardy GG, Yother J. Capsule genetics in Streptococcus pneumoniae and a possible role for transposition in the generation of the type 3 locus. Microb Drug Resist 1998; 4:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/55\">",
"      Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2009*. Ann Intern Med 2009; 150:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/56\">",
"      Kuehn BM. CDC panel recommends vaccine for smokers; reviews HPV safety data. JAMA 2008; 300:2713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/57\">",
"      Centers for Disease Control and Prevention (CDC). Influenza and pneumococcal vaccination coverage among persons aged &gt; or = 65 years--United States, 2004-2005. MMWR Morb Mortal Wkly Rep 2006; 55:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/58\">",
"      Singleton JA, Greby SM, Wooten KG, et al. Influenza, pneumococcal, and tetanus toxioid vaccination of adults--United States, 1993-7. MMWR CDC Surveill Summ 2000; 49:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/59\">",
"      Sisk JE, Whang W, Butler JC, et al. Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: role of comorbid conditions and race. Ann Intern Med 2003; 138:960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/60\">",
"      Gardner P. A need to update and revise the pneumococcal vaccine recommendations for adults. Ann Intern Med 2003; 138:999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/61\">",
"      Greene CM, Kyaw MH, Ray SM, et al. Preventability of invasive pneumococcal disease and assessment of current polysaccharide vaccine recommendations for adults: United States, 2001-2003. Clin Infect Dis 2006; 43:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/62\">",
"      Honkanen PO, Keistinen T, Kivel&auml; SL. Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly. Arch Intern Med 1996; 156:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/63\">",
"      Mufson MA, Krause HE, Schiffman G, Hughey DF. Pneumococcal antibody levels one decade after immunization of healthy adults. Am J Med Sci 1987; 293:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21705/abstract/64\">",
"      Walker FJ, Singleton RJ, Bulkow LR, et al. Reactions after 3 or more doses of pneumococcal polysaccharide vaccine in adults in Alaska. Clin Infect Dis 2005; 40:1730.",
"     </a>",
"    </li>",
"    <li>",
"     PNEUMOVAX 23 (pneumococcal vaccine polyvalent) sterile, liquid vaccine for intramuscular or subcutaneous injection - prescribing information. file://www.merck.com/product/usa/pi_circulars/p/pneumovax_23/pneumovax_pi.pdf (Accessed on March 14, 2012).",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7021 Version 23.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-222.190.118.195-4B2100FB5C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_12_21705=[""].join("\n");
var outline_f21_12_21705=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H256255\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      POLYSACCHARIDE VACCINES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Efficacy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H625089405\">",
"      - Invasive pneumococcal disease, pneumonia, and mortality",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H625089275\">",
"      - Stroke and myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H573915\">",
"      - Comorbidities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H625089217\">",
"      COPD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H625089239\">",
"      Immunocompromised hosts",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2155317327\">",
"      - Dual pneumococcal and influenza vaccination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CONJUGATE VACCINES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2155316754\">",
"      POLYSACCHARIDE PLUS CONJUGATE VACCINES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      INVESTIGATIONAL APPROACHES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      VACCINE ADMINISTRATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H573510\">",
"      Revaccination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H256255\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/7021\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7021|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/26/10658\" title=\"figure 1\">",
"      Rates of IPD after PCV7",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7021|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/48/12046\" title=\"table 1\">",
"      Pneumococcal vaccination indications for adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/48/24328?source=related_link\">",
"      Assessing the immunologic response to vaccination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/57/25498?source=related_link\">",
"      Immunizations after hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/53/32602?source=related_link\">",
"      Immunizations during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37273?source=related_link\">",
"      Immunizations in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/37/30296?source=related_link\">",
"      Immunizations in patients with cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/48/23306?source=related_link\">",
"      Immunizations in solid organ transplant candidates and recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/37/601?source=related_link\">",
"      Impact of universal infant immunization with pneumococcal (Streptococcus pneumoniae) conjugate vaccines in the United States",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22810?source=related_link\">",
"      Initial therapy and prognosis of bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/29/7642?source=related_link\">",
"      Invasive pneumococcal (Streptococcus pneumoniae) infections and bacteremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23143?source=related_link\">",
"      Microbiology and pathogenesis of Streptococcus pneumoniae",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/57/14225?source=related_link\">",
"      Patient information: Pneumonia prevention (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/48/12035?source=related_link\">",
"      Patient information: Vaccines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/4/23619?source=related_link\">",
"      Patient information: Vaccines for adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7402?source=related_link\">",
"      Pneumococcal (Streptococcus pneumoniae) conjugate vaccines in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/38/13926?source=related_link\">",
"      Pneumococcal (Streptococcus pneumoniae) polysaccharide vaccines in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/4/13386?source=related_link\">",
"      Pneumococcal pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/5/81?source=related_link\">",
"      Resistance of Streptococcus pneumoniae to beta-lactam antibiotics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/18/3369?source=related_link\">",
"      Resistance of Streptococcus pneumoniae to the fluoroquinolones, doxycycline, and trimethoprim-sulfamethoxazole",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19704?source=related_link\">",
"      Resistance of Streptococcus pneumoniae to the macrolides, azalides, lincosamines, and ketolides",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_12_21706="Clinical features and evaluation of aortic stenosis in adults";
var content_f21_12_21706=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features and evaluation of aortic stenosis in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/12/21706/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/12/21706/contributors\">",
"     Catherine M Otto, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/12/21706/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/12/21706/contributors\">",
"     William H Gaasch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/12/21706/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/12/21706/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/12/21706/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 31, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Left ventricular outflow obstruction in adults is most often due to aortic valve stenosis; less common causes are subvalvular or supravalvular disease (",
"    <a class=\"graphic graphic_table graphicRef51024 \" href=\"UTD.htm?42/11/43196\">",
"     table 1",
"    </a>",
"    ). This topic will review the pathophysiology, clinical features, and evaluation of valvular aortic stenosis (AS).",
"   </p>",
"   <p>",
"    The natural history, medical therapy, and timing of valve replacement are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/53/30551?source=see_link\">",
"     \"Natural history of aortic stenosis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/62/2025?source=see_link\">",
"     \"Medical management of asymptomatic aortic stenosis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/8/31881?source=see_link\">",
"     \"Indications for valve replacement in aortic stenosis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ETIOLOGY OF VALVULAR AS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are three primary causes of valvular AS:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A congenitally abnormal valve with superimposed calcification (unicuspid or bicuspid) (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/1/6169?source=see_link\">",
"       \"Clinical manifestations and diagnosis of bicuspid aortic valve\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Calcific disease of a trileaflet valve",
"     </li>",
"     <li>",
"      Rheumatic valve disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Rare causes include metabolic diseases (eg, Fabry's disease), systemic lupus erythematosus, Paget disease, and alkaptonuria. Calcific AS has also been associated with chronic kidney disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Relative frequency",
"    </span>",
"    &nbsp;&mdash;&nbsp;The relative frequency of the causes of aortic valve disease varies geographically. Worldwide, rheumatic valve disease is most common; mitral valve involvement invariably accompanies rheumatic aortic valve disease. In North America and Europe, aortic valve disease is primarily due to calcific disease of a native trileaflet or a congenital bicuspid valve.",
"   </p>",
"   <p>",
"    The relative prevalence of trileaflet versus congenitally abnormal valves according to age was examined in a series of 932 adults who underwent surgery for isolated AS [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/1\">",
"     1",
"    </a>",
"    ]. Patients with mitral valve replacement or mitral stenosis were excluded to ensure that patients with rheumatic valve disease were not included. Also excluded were patients with a previous aortic valvotomy, indicating severe valve obstruction due to congenital disease.",
"   </p>",
"   <p>",
"    An anatomically abnormal valve was present in 54 percent: 49 percent had a bicuspid valve and 4 percent had a unicuspid valve, but the frequency varied importantly with age:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among the 7 percent of patients who underwent surgery at &le;50 years of age, approximately two-thirds had a bicuspid valve and one-third had a unicuspid valve. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/1/6169?source=see_link\">",
"       \"Clinical manifestations and diagnosis of bicuspid aortic valve\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Among the 40 percent of patients who underwent surgery between the ages of 50 and 70, approximately two-thirds had a bicuspid valve and one-third a tricuspid valve; only rare patients had a unicuspid valve.",
"     </li>",
"     <li>",
"      Among the remaining patients over age 70, approximately 60 percent had a tricuspid valve and 40 percent had a bicuspid valve. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/36/34377?source=see_link&amp;anchor=H2#H2\">",
"       \"Valvular heart disease in elderly adults\", section on 'Aortic stenosis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26904730\">",
"    <span class=\"h3\">",
"     Pathobiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rheumatic valve disease is characterized by fusion of the commissures between the leaflets, with a small central orifice. Histologic studies show typical changes due to rheumatic disease. The rheumatic process typically involves the mitral valve as well; as a result, most patients with rheumatic aortic stenosis also have mitral stenosis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mitral regurgitation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/8/8327?source=see_link\">",
"     \"Epidemiology and pathogenesis of acute rheumatic fever\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/20/23879?source=see_link\">",
"     \"Clinical manifestations and diagnosis of acute rheumatic fever\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Calcific aortic valve disease is characterized by aortic valve leaflet thickening and calcification in patients with a congenital bicuspid valve or an anatomically normal trileaflet valve [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/2\">",
"     2",
"    </a>",
"    ]. The pathobiology of calcific aortic valve disease is characterized by three primary processes: lipid accumulation, inflammation, and calcification.",
"   </p>",
"   <p>",
"    At the tissue level, the valve leaflets show the following features [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Accumulation of LDL and Lp(a) with evidence of lipoprotein oxidation [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/4,5\">",
"       4,5",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      An inflammatory cell infiltrate with T-lymphocytes and macrophages [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/4,6\">",
"       4,6",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Local production of proteins that promote tissue calcification, suggesting that valve calcification is actively regulated rather than being an unregulated degenerative process [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/7-11\">",
"       7-11",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Production and activity of angiotensin converting enzyme [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/12,13\">",
"       12,13",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Other inflammatory mediators such as interleukin-1-beta and transforming growth factor beta-1 [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/14,15\">",
"       14,15",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Upregulation of adhesion molecules and alterations in matrix metalloproteinase activity [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/16,17\">",
"       16,17",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A positron electron imaging study using 18F-NaF to demonstrate calcification and 18F-FGD to show inflammation in a series of adults with a range of calcific aortic valve severity demonstrated inflammation in early disease and progressive calcification with more severe disease in vivo [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Late in the disease process, active cartilage and bone formation are present. This was demonstrated in a pathologic study of 256 end-stage excised calcified aortic valves, 83 percent of which showed heterotopic ossification on histologic examination [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Progression from aortic sclerosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Calcific aortic valve disease may progress to obstruction to blood flow because the thickened, stiff leaflets do not open fully with ventricular ejection. Unlike atherosclerosis, where clinical events are due to plaque rupture and thrombosis, obstruction in calcific AS is due to the bulk of the lesion, with no evidence for plaque instability.",
"   </p>",
"   <p>",
"    It is likely that the disease process is accelerated by abnormal shear or mechanical stress on the leaflet. This could explain why symptomatic calcification in patients with bicuspid aortic valves occurs about 10 years earlier than in patients with trileaflet valves. In most patients, a bicuspid aortic valve functions normally for many years. A subset of patients develop significant regurgitation, but most are asymptomatic until superimposed calcification results in obstruction to flow later in life. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/1/6169?source=see_link\">",
"     \"Clinical manifestations and diagnosis of bicuspid aortic valve\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The frequency of and risk factors for progression of aortic valve thickening (sclerosis) to aortic stenosis is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/24/38279?source=see_link\">",
"     \"Aortic valve sclerosis\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Association with atherosclerosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many of the risk factors for atherosclerosis are also associated with aortic valve sclerosis, which has led to the suggestion that calcific aortic valve disease is an atherosclerotic-like process [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. Associations between aortic sclerosis and atherosclerosis and atherosclerosis risk factors are discussed in detail separately. These include an association between aortic sclerosis and diabetes or metabolic syndrome, an established predictor of premature atherosclerosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/24/38279?source=see_link&amp;anchor=H7#H7\">",
"     \"Aortic valve sclerosis\", section on 'Relation to atherosclerosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Metabolic syndrome may also be associated with progression of AS. In a retrospective study of 105 patients with moderate to severe AS, 38 percent met the clinical criteria for the metabolic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/22\">",
"     22",
"    </a>",
"    ] (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32954?source=see_link\">",
"     \"The metabolic syndrome (insulin resistance syndrome or syndrome X)\"",
"    </a>",
"    ). Echocardiographic progression of AS and clinical outcomes, including aortic valve replacement and death, were evaluated at a mean follow-up of 28 months. The patients with metabolic syndrome had more rapid echocardiographic progression of disease and a significantly lower three-year event-free survival (44 versus 69 percent in those without the metabolic syndrome).",
"   </p>",
"   <p>",
"    Although calcific AS shares many similarities with atherosclerosis, there also are significant differences [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. In addition, there is no convincing evidence that statin therapy can slow disease progression once even mild valve obstruction is present. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/62/2025?source=see_link&amp;anchor=H4#H4\">",
"     \"Medical management of asymptomatic aortic stenosis in adults\", section on 'Hypercholesterolemia and statin therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Genetic factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genetic factors play a role in at least a subset of AS patients. As an example, mutations in the signaling and transcriptional regulator NOTCH1 are associated with a variety of aortic valve anomalies (such as bicuspid aortic valve with or without thoracic aortic aneurysm) and with severe aortic valve calcification in human pedigrees in a nonsyndromic autosomal dominant pattern [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. NOTCH1 transcripts are abundant in the developing aortic valve in mice and may promote valve calcification by diminishing the activity of Runx2, an important transcriptional regulator of the fate of osteoblast cells. This observation is consistent with the suggestion that aortic valve calcification is an active process mediated by the differentiation of valvular cells into osteoblast-like cells [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/9,23\">",
"     9,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A familial aggregation of calcific aortic stenosis with apparent autosomal dominant inheritance was noted in a report from western France [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/25\">",
"     25",
"    </a>",
"    ]. This aggregation could not be explained by hypercholesterolemia or chronic kidney disease; but a specific genetic abnormality has not yet been identified. Other risk factors for calcific aortic valve disease include specific polymorphisms in the genes for apolipoprotein E, interleukin-10, the vitamin D receptor, and angiotensin-converting enzyme [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/26-29\">",
"     26-29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Other factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Calcific AS presents at a younger age and progresses more rapidly in patients with combined familial hypercholesterolemia, Paget disease or end-stage renal disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/59/954?source=see_link&amp;anchor=H17#H17\">",
"     \"Valvular heart disease in patients with end-stage renal disease\", section on 'Valvular stenosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/50/7978?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Paget disease of bone\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     HEMODYNAMIC PROGRESSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In individuals with normal aortic valves, the effective area of valve opening equals the cross-sectional area of the left ventricular outflow tract, which is about 3.0 to 4.0 cm",
"    <sup>",
"     2",
"    </sup>",
"    in adults. As AS develops, the antegrade velocity remains normal and there is a minimal valve gradient until the orifice area reaches less than half of normal. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/11/1208?source=see_link\">",
"     \"Aortic valve area in aortic stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Calcific aortic valve disease without a significant gradient (defined as an aortic jet velocity &le;2.5",
"    <span class=\"nowrap\">",
"     m/sec)",
"    </span>",
"    is called aortic valve sclerosis. Aortic stenosis is present when the antegrade velocity across an abnormal valve is at least 2.6",
"    <span class=\"nowrap\">",
"     m/sec.",
"    </span>",
"    Stenosis severity is based upon echocardiographic estimation of the aortic jet velocity, mean transvalvular gradient, and aortic valve area (",
"    <a class=\"graphic graphic_table graphicRef65280 \" href=\"UTD.htm?17/33/17948\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/24/38279?source=see_link\">",
"     \"Aortic valve sclerosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/3/1082?source=see_link\">",
"     \"Echocardiographic evaluation of the aortic valve\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When AS becomes hemodynamically significant, it results in obstruction to left ventricular ejection. The stenotic process is gradual in onset and progression, resulting in adaptive changes in the left ventricle. The increased systolic pressure in the ventricular chamber, leads to concentric hypertrophy as a mechanism to maintain normal wall stress.",
"   </p>",
"   <p>",
"    With a compensated ventricle, the cardiac output and left ventricular end-diastolic volume are maintained for a prolonged period despite a systolic pressure gradient between the left ventricle and peripheral arterial system. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/41/3737?source=see_link\">",
"     \"Hemodynamics of valvular disorders as measured by cardiac catheterization\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, as stenosis severity and hypertrophy continue to progress, the left ventricle becomes less compliant and left ventricular end-diastolic pressure can become elevated even though the ventricular size remains normal. Abnormal diastolic function contributes to symptom onset and may persist after relief of stenosis due to persistent interstitial fibrosis. Another contributing factor to the reduction in ventricular function is incoordinate contraction, resulting from regional wall motion abnormalities, fibrosis, or subendocardial ischemia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In general, symptoms in patients with aortic stenosis and normal left ventricular systolic function rarely occur until the valve area is &lt;1.0 cm",
"    <sup>",
"     2",
"    </sup>",
"    , the jet velocity is over 4.0",
"    <span class=\"nowrap\">",
"     m/sec,",
"    </span>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the mean transvalvular gradient exceeds 40 mm Hg (",
"    <a class=\"graphic graphic_table graphicRef65280 \" href=\"UTD.htm?17/33/17948\">",
"     table 2",
"    </a>",
"    ). However, many patients do not develop symptoms until even more severe valve obstruction is present, while some patients become symptomatic when the stenosis is less severe, particularly if there is coexisting aortic regurgitation.",
"   </p>",
"   <p>",
"    Most patients with AS develop symptoms before the onset of left ventricular systolic dysfunction. However, in some patients, there is a reduction in systolic myocardial function and a decrease in the ability of the left ventricle to develop pressure and shorten against a load before the onset of symptoms. At this point, the left ventricle fails, resulting in reductions in stroke volume and cardiac output, and eventual heart failure. In addition, the marked elevation in left ventricular pressure can produce or exacerbate mitral regurgitation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21855074\">",
"    <span class=\"h1\">",
"     OTHER CAUSES OF LEFT VENTRICULAR OUTFLOW OBSTRUCTION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21855144\">",
"    <span class=\"h2\">",
"     Subvalvular disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subvalvular AS can result from a variety of fixed lesions. These include a thin membrane (the most common lesion), thick fibromuscular ridge, diffuse tunnel-like obstruction, abnormal mitral valve attachments, and occasionally, accessory endocardial cushion tissue. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/27/33207?source=see_link\">",
"     \"Subvalvar aortic stenosis (subaortic stenosis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Subvalvular AS also may have a dynamic component that is primarily seen in the genetic disease hypertrophic cardiomyopathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/59/28600?source=see_link\">",
"     \"Types and pathophysiology of obstructive hypertrophic cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21855151\">",
"    <span class=\"h2\">",
"     Supravalvular disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are at least two anatomic forms of supravalvar AS. The majority of patients (60 to 75 percent) have an hourglass deformity, consisting of a discrete constriction of a thickened ascending aorta at the superior aspect of the sinuses of Valsalva (the \"hourglass deformity\") (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef56928 \" href=\"UTD.htm?15/62/16355\">",
"     image 1",
"    </a>",
"    ). More diffuse narrowing for a variable distance along the ascending aorta is seen in the remaining patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/52/40774?source=see_link\">",
"     \"Supravalvar aortic stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is a high frequency of supravalvular AS in patients with Williams syndrome, which is due to a mutation in the elastin gene. Supravalvular AS is also common in patients with homozygous familial hypercholesterolemia and occurs infrequently in heterozygotes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37274?source=see_link\">",
"     \"Inherited disorders of LDL-cholesterol metabolism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient with AS is asymptomatic for a prolonged period despite the obstruction and increased pressure load on the left ventricle. There is wide variability in the degree of outflow obstruction that causes symptoms, depending in part upon patient size and level of physical activity. As a result, there is no single value that defines severe valve obstruction.",
"   </p>",
"   <p>",
"    The classic symptoms due to AS are heart failure (HF), syncope, and angina. However, these &ldquo;classic&rdquo; symptoms reflect end-stage disease. Now, with earlier diagnosis by echocardiography and prospective followup of patients, the most common presenting symptoms are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Dyspnea on exertion or decreased exercise tolerance",
"     </li>",
"     <li>",
"      Exertional dizziness",
"     </li>",
"     <li>",
"      Exertional angina",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In adults with moderate AS, care should be taken to avoid attributing noncardiac symptoms to aortic stenosis: dyspnea may be due to deconditioning or lung disease, ankle edema has many causes other than heart failure, and nonanginal chest or shoulder pain is not a symptom of AS. However, when severe AS is present, even mild cardiac symptoms require prompt surgical intervention because average survival without valve replacement is only two to three years, with a high risk of sudden death (",
"    <a class=\"graphic graphic_figure graphicRef83004 \" href=\"UTD.htm?40/22/41327\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/53/30551?source=see_link&amp;anchor=H21854682#H21854682\">",
"     \"Natural history of aortic stenosis in adults\", section on 'Prognosis of symptomatic AS'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/8/31881?source=see_link\">",
"     \"Indications for valve replacement in aortic stenosis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Dyspnea and decreased exercise tolerance",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common symptom of AS is dyspnea, usually with exertion. Two factors can contribute: diastolic dysfunction, with an increase in left ventricular filling pressures with exercise, and an inability of the left ventricle to increase the cardiac output during exercise because the stiff aortic valve obstructs flow. &nbsp;",
"   </p>",
"   <p>",
"    Systolic left ventricular dysfunction is rare and overt HF is a late, often end-stage finding, usually in patients who have not received regular medical care. Once overt HF occurs, the patient may complain of shortness of breath, easy fatigability, debilitation, and other signs and symptoms of a low cardiac output state.",
"   </p>",
"   <p>",
"    Atrial fibrillation (AF), which is uncommon in isolated AS, often accompanies HF. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Arrhythmias'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Dizziness and syncope",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several proposed explanations for exertional dizziness or syncope, both of which reflect decreased cerebral perfusion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/9/5272?source=see_link\">",
"     \"Pathogenesis and etiology of syncope\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Exercise-induced vasodilation in the presence of an obstruction with fixed cardiac output can result in hypotension",
"     </li>",
"     <li>",
"      A transient bradyarrhythmia that can occur during or immediately after exertion",
"     </li>",
"     <li>",
"      Abnormalities in the baroreceptor response with an ensuing failure to appropriately increase the blood pressure",
"     </li>",
"     <li>",
"      An arrhythmia, such as atrial fibrillation; ventricular arrhythmias are uncommon.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Angina pectoris",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angina with effort occurs in about two-thirds of patients with severe AS. Approximately one-half of these patients have underlying coronary artery disease. (See",
"    <a class=\"local\" href=\"#H29\">",
"     'Coronary disease'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Angina in the remaining patients has been attributed to left ventricular hypertrophy, which can cause coronary ischemia by other mechanisms [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/34\">",
"     34",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increased left ventricular oxygen demand as a result of increased left ventricular mass; the myocardial oxygen uptake per gram is normal",
"     </li>",
"     <li>",
"      Compression of intramyocardial coronary arteries from prolonged contraction and impaired myocardial relaxation",
"     </li>",
"     <li>",
"      Reduced diastolic coronary perfusion time during tachycardia",
"     </li>",
"     <li>",
"      Reduced coronary flow reserve",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An additional factor that may contribute to angina was identified by a study of intracoronary pressures and flow velocities [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/35\">",
"     35",
"    </a>",
"    ]. Coronary diastolic suction fell (rather than rose) with increasing heart rate in patients with severe AS. Appropriate increase in coronary diastolic suction with increasing heart rate was restored immediately after transcatheter aortic valve implantation. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination often provides the first clue to the presence of AS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=see_link\">",
"     \"Auscultation of cardiac murmurs\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/56/22410?source=see_link\">",
"     \"Auscultation of heart sounds\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A review of clinical studies evaluated the published evidence on the precision and accuracy of the clinical examination for abnormal systolic murmurs; most studies used cardiology examiners [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/36\">",
"     36",
"    </a>",
"    ]. Three findings were most useful for ruling in AS:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A slow rate of rise in the carotid pulse",
"     </li>",
"     <li>",
"      Mid to late peak intensity of the murmur",
"     </li>",
"     <li>",
"      Reduced intensity of the second heart sound",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a later study from the same authors, maximal murmur intensity at the second right intercostal space was also suggestive and patients with three of these four findings were very likely to have aortic stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/37\">",
"     37",
"    </a>",
"    ]. On the other hand, the most useful finding for ruling out aortic stenosis was absence of a systolic murmur radiating to the right carotid artery or right clavicle [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/36,37\">",
"     36,37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The quality of the pulse, murmur intensity and timing, and abnormalities in S2 correlate with the severity of AS. In one report, carotid upstroke delay, carotid pulse amplitude, murmur intensity, murmur peak, and a single second heart sound correlated with AS severity [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the classic findings of severe AS are accurate for confirming the presence of severe valve obstruction, the physical examination is less useful for excluding the presence of severe AS in patients with symptoms and a systolic murmur. Echocardiography is still necessary, since none of the physical findings has both a high sensitivity and high specificity for severe valvular obstruction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Carotid pulse",
"    </span>",
"    &nbsp;&mdash;&nbsp;The quality of the arterial pulse in AS reflects the obstruction to blood flow into the peripheral arterial circulation. The arterial pulse has been described as \"parvus and tardus\", ie, it is small or weak and rises slowly. This is best appreciated in the carotid artery where the pulse is reduced in amplitude and delayed in occurrence. The delay can be appreciated by simultaneous palpation of the apex (point of maximum impulse) and the carotid artery. There may also be an associated carotid artery thrill or coarse vibration (\"shuddering\") due to the marked turbulence of blood flow across the stenotic valve. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/15/33013?source=see_link\">",
"     \"Examination of the arterial pulse\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Precordial palpation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cardiac impulse at the apex is sustained and is initially normal in location. However, it becomes displaced late in the course of AS when left ventricular failure occurs. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/43/9909?source=see_link\">",
"     \"Examination of the precordial pulsation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some patients have a palpable fourth heart sound (S4) due to vigorous left atrial contraction into the noncompliant ventricle. In addition, a systolic thrill may be felt at the base of the heart (second intercostal space) or at the sternal notch, especially during full expiration with the patient leaning forward.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Cardiac auscultation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stenosis of the aortic leaflets is associated with reduced mobility and delayed closure. This leads to the following changes in the heart sounds. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=see_link\">",
"     \"Auscultation of cardiac murmurs\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/56/22410?source=see_link\">",
"     \"Auscultation of heart sounds\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      S2 is soft and single since A2, which is due to aortic valve closure, is delayed and tends to occur simultaneously with P2, which is due to pulmonic valve closure. The S2 may become paradoxically split when the stenosis is severe and associated with left ventricular dysfunction (",
"      <a class=\"graphic graphic_movie graphicRef67896 \" href=\"UTD.htm?13/13/13521\">",
"       movie 1",
"      </a>",
"      ). With increasingly severe, fixed AS, the A2 closing sound may disappear. The presence of a normal split S2 is the most reliable finding to exclude severe AS in adults.",
"     </li>",
"     <li>",
"      The first heart sound (S1) is usually normal. However, an aortic ejection click, which is more commonly heard with a congenital bicuspid valve, may be heard after S1 early in AS when the leaflets are stiff, but still somewhat compliant and mobile (",
"      <a class=\"graphic graphic_movie graphicRef77091 \" href=\"UTD.htm?39/8/40065\">",
"       movie 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_movie graphicRef72877 \" href=\"UTD.htm?43/6/44128\">",
"       movie 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Vigorous left atrial contraction can lead to a fourth heart sound (S4).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The murmur associated with AS is described as a systolic \"ejection\" murmur. It is typically heard best at the base of the heart in the \"aortic\" area (second intercostal space on the right) where it has a harsh quality (",
"    <a class=\"graphic graphic_movie graphicRef77091 \" href=\"UTD.htm?39/8/40065\">",
"     movie 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef56063 \" href=\"UTD.htm?20/22/20832\">",
"     movie 4",
"    </a>",
"    ). The murmur is transmitted well and equally to the carotid arteries. Diminished intensity in one carotid artery may indicate the presence of a stenosis in that vessel.",
"   </p>",
"   <p>",
"    The murmur generally begins after S1 and ends before S2. The intensity of the murmur reflects the amount and velocity of blood flow across the valve and the turbulence produced by the stenosis. A loud murmur (grade 4 or greater) has a high specificity for severe aortic stenosis. However, most patients with severe stenosis have a grade 3 murmur and many have only a grade 1 or 2 murmur.",
"   </p>",
"   <p>",
"    The timing of the murmur also correlates with the severity of the stenosis, similar to the timing of the carotid pulse. An early peaking murmur is typical for mild to moderate AS, while a late peaking murmur is consistent with severe AS. However, evaluation of the timing of the murmur is not reproducible among examiners and is therefore of limited clinical utility.",
"   </p>",
"   <p>",
"    The murmur may also radiate to the apex of the heart where it may have a different quality (musical due to high frequency vibrations) and may be louder, suggesting that the patient also has mitral regurgitation. This is known as the Gallavardin phenomenon. Another finding that has led to the misperception of two murmurs with different etiologies is that the murmur is often softer or even inaudible in the chest area between the apex and base.",
"   </p>",
"   <p>",
"    In almost all patients, AS is associated with a small degree of aortic regurgitation since the stiff, calcified, and rigid aortic valve leaflets may not coapt normally. In this setting, a soft diastolic murmur of aortic regurgitation may be heard. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/9/38039?source=see_link\">",
"     \"Pathophysiology, clinical features, and evaluation of chronic aortic regurgitation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     OTHER CLINICAL MANIFESTATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Sudden cardiac death",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, symptomatic severe aortic stenosis is associated with a high risk of sudden cardiac death. Sudden death has been observed in 0 to 5 percent of adults with asymptomatic aortic stenosis and in 8 to 34 percent with symptomatic aortic stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mechanism of sudden death has not been established. Potential causes include an abnormal Bezold-Jarisch reflex with hypotension or bradyarrhythmias or malignant ventricular tachyarrhythmias [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/39\">",
"     39",
"    </a>",
"    ]. However, a relationship between NSVT and sudden death has not been established.",
"   </p>",
"   <p>",
"    The risk of sudden death is reduced by valve replacement, so prompt valve replacement is generally recommended for symptomatic aortic stenosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/8/31881?source=see_link\">",
"     \"Indications for valve replacement in aortic stenosis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Arrhythmias",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Atrial fibrillation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atrial fibrillation (AF), which is uncommon in isolated AS, often accompanies HF. AF can be life-threatening in severe AS because the loss of atrial contraction and the rapid heart rate both limit diastolic filling of the small, stiff left ventricle. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/62/2025?source=see_link&amp;anchor=H17#H17\">",
"     \"Medical management of asymptomatic aortic stenosis in adults\", section on 'Atrial fibrillation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Ventricular arrhythmias",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ventricular premature beats (VPBs) and nonsustained ventricular tachycardia (NSVT) are common in patients with aortic stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/39\">",
"     39",
"    </a>",
"    ]. The frequency and complexity of ventricular arrhythmias correlate with myocardial dysfunction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Endocarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infective endocarditis (IE) can occur in patients with AS, particularly those with a congenitally bicuspid aortic valve. In a series of 2401 patients with congenital heart lesions who were followed prospectively, those with AS developed IE at a rate of 0.27 percent per year [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/40\">",
"     40",
"    </a>",
"    ]. A higher peak gradient across the aortic valve was associated with a greater risk of IE. Although definitive data are lacking, clinical experience suggests that the risk of IE is lower in older patients with heavily calcified valves than in younger patients with less severe abnormalities.",
"   </p>",
"   <p>",
"    The 2007 American Heart Association guidelines on infective endocarditis revised prior recommendations for patients with acquired valvular disease, including those with aortic stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/41\">",
"     41",
"    </a>",
"    ]. As a result, antibiotic prophylaxis is",
"    <strong>",
"     no longer",
"    </strong>",
"    recommended when such patients undergo dental or other invasive procedures that produce significant bacteremia with organisms associated with endocarditis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/62/2025?source=see_link&amp;anchor=H9#H9\">",
"     \"Medical management of asymptomatic aortic stenosis in adults\", section on 'Endocarditis prophylaxis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=see_link\">",
"     \"Antimicrobial prophylaxis for bacterial endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Bleeding tendency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with AS have an increased risk of bleeding, including chronic gastrointestinal bleeding that is often due to angiodysplasia (arteriovenous malformation, Heyde's syndrome), and bleeding at skin and mucosal sites. In a series of 42 patients with severe AS who underwent aortic valve replacement, for example, nine had a history of skin or mucosal bleeding (causing manifestations such as epistaxis and ecchymoses) and four had a history of gastrointestinal bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/13/8410?source=see_link&amp;anchor=H7#H7\">",
"     \"Angiodysplasia of the gastrointestinal tract\", section on 'Aortic stenosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The increased risk of bleeding appears to be due to an acquired von Willebrand syndrome, which has been described in 67 to 92 percent of patients with severe AS [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/42\">",
"     42",
"    </a>",
"    ]. This abnormality is thought to result from mechanical disruption of von Willebrand multimers during turbulent passage through the narrowed valve and from a von Willebrand factor interaction with platelets that triggers platelet clearance [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. The severity of the von Willebrand factor abnormality is directly related to the severity of the AS, as measured by the mean transvalvular gradient [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/8/44169?source=see_link&amp;anchor=H13#H13\">",
"     \"Classification and pathophysiology of von Willebrand disease\", section on 'Acquired von Willebrand disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most likely explanation for the association with angiodysplasia is that patients with AS have an increased bleeding tendency, leading to the identification of angiodysplasia. This issue is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/13/8410?source=see_link&amp;anchor=H7#H7\">",
"     \"Angiodysplasia of the gastrointestinal tract\", section on 'Aortic stenosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are several clinical implications of the increased risk of bleeding in patients with AS:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with moderate to severe AS who are treated with antiplatelet agents may be at greater risk of mucosal bleeding [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Although not documented, patients with moderate to severe AS who undergo noncardiac surgery may be at greater risk of surgical bleeding. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/62/2025?source=see_link&amp;anchor=H20#H20\">",
"       \"Medical management of asymptomatic aortic stenosis in adults\", section on 'Noncardiac surgery'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      While bleeding is not regarded as an adequate indication for aortic valve replacement, there could be individual patients with severe bleeding for whom this might be considered. Although the bleeding resolves in most patients, the defect in hemostasis can recur or the improvement can be minimized in patients who receive a small prosthesis for their body size (prosthetic valve patient mismatch, effective orifice area less than 0.8",
"      <span class=\"nowrap\">",
"       cm2/m2",
"      </span>",
"      body surface area) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/42,44\">",
"       42,44",
"      </a>",
"      ]; recurrence may also be seen in those who develop restenosis [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/42\">",
"       42",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/53/36697?source=see_link&amp;anchor=H19#H19\">",
"       \"Surgical procedures for severe chronic mitral regurgitation\", section on 'Prosthetic valve-patient mismatch'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Embolic events",
"    </span>",
"    &nbsp;&mdash;&nbsp;Isolated case reports have described cerebral or systemic embolic events due to calcium emboli in patients with AS. This appears to be an infrequent complication. In a cohort study that included 515 patients with calcific AS, 300 with aortic valve calcification without stenosis, and 562 controls, the stroke rates were not different at two years (5, 8, and 5 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Coronary disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe isolated AS is primarily a disease of older patients. In a report cited above of 932 adults who underwent surgery for isolated AS, almost all were over age 50 and more than one-half were over age 70 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/1\">",
"     1",
"    </a>",
"    ]. Thus, adults with moderate to severe AS have a high prevalence of coexisting coronary disease and are at risk for clinical events due to coronary disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/62/2025?source=see_link&amp;anchor=H11#H11\">",
"     \"Medical management of asymptomatic aortic stenosis in adults\", section on 'Coronary artery disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The magnitude of risk was illustrated in a prospective study of 123 adults with asymptomatic aortic stenosis who were followed for an average of 2.5 years. Myocardial infarction occurred in 3 percent, percutaneous coronary intervention in 2 percent, and coronary artery bypass grafting without valve replacement in 2 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Echocardiography has largely replaced cardiac catheterization for hemodynamic measurements to assess the severity of aortic stenosis. The electrocardiogram and chest radiograph generally show non-specific findings and may reveal concurrent conditions. The 2006 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart Association",
"    <span class=\"nowrap\">",
"     (ACC/AHA)",
"    </span>",
"    guidelines on the management of valvular heart disease included recommendations for the diagnostic evaluation of adolescents and young adults with congenital AS (",
"    <a class=\"graphic graphic_table graphicRef72431 \" href=\"UTD.htm?18/39/19068\">",
"     table 3",
"    </a>",
"    ) and the use of echocardiography in patients with asymptomatic or symptomatic murmurs (",
"    <a class=\"graphic graphic_table graphicRef50108 graphicRef58419 \" href=\"UTD.htm?39/46/40684\">",
"     table 4A-B",
"    </a>",
"    ) and for the evaluation and monitoring of older patients with known AS (",
"    <a class=\"graphic graphic_table graphicRef80790 \" href=\"UTD.htm?14/18/14635\">",
"     table 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The separate issue of coronary angiography at the time of aortic valve replacement to identify patients who might also benefit from coronary artery bypass graft surgery is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/8/31881?source=see_link&amp;anchor=H20#H20\">",
"     \"Indications for valve replacement in aortic stenosis in adults\", section on 'Aortic valve replacement and CABG'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Electrocardiogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary electrocardiographic findings in AS are related to the presence of left ventricular hypertrophy and are therefore not specific. The voltage of the QRS complex is markedly increased (",
"    <a class=\"graphic graphic_waveform graphicRef69040 \" href=\"UTD.htm?41/58/42922\">",
"     waveform 1",
"    </a>",
"    ), there are often associated ST-T wave changes that reflect chronic subendocardial ischemia (",
"    <a class=\"graphic graphic_waveform graphicRef76497 \" href=\"UTD.htm?41/57/42906\">",
"     waveform 2",
"    </a>",
"    ), and there may be left atrial hypertrophy. However, the absence of hypertrophy on the ECG does",
"    <strong>",
"     not",
"    </strong>",
"    exclude the presence of severe AS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/13/3285?source=see_link\">",
"     \"Electrocardiographic diagnosis of left ventricular hypertrophy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Intraventricular or atrioventricular conduction abnormalities are uncommon and, when present, may be due to severe hypertrophy, extension of calcium from the valve and valve ring into the interventricular septum, or concomitant heart disease. Ventricular and supraventricular arrhythmias are also uncommon and, when present, are usually a reflection of underlying left ventricular dysfunction.",
"   </p>",
"   <p>",
"    Atrial fibrillation is usually a late arrhythmia, primarily occurring in association with heart failure. Thus, associated mitral valve disease should be suspected if atrial fibrillation occurs in mild to moderate AS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/62/2025?source=see_link&amp;anchor=H17#H17\">",
"     \"Medical management of asymptomatic aortic stenosis in adults\", section on 'Atrial fibrillation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Chest radiograph",
"    </span>",
"    &nbsp;&mdash;&nbsp;The routine chest radiograph is usually normal when AS is mild to moderate. There are, however, a number of findings that may be seen:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A rounding of the left ventricular apex suggests left ventricular hypertrophy.",
"     </li>",
"     <li>",
"      Calcification of the aortic leaflets and aortic root is present in most adults with hemodynamically significant AS but is rarely seen on routine chest radiography (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef74730 \" href=\"UTD.htm?10/58/11170\">",
"       image 2",
"      </a>",
"      ); however, calcification may be visible on an overpenetrated chest x-ray or fluoroscopy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The findings are different in children or young adults with congenital AS. In this setting, the leaflets may be severely fibrotic and immobile in the absence of calcification. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/28/38345?source=see_link\">",
"     \"Valvar aortic stenosis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Another helpful finding is dilatation of the ascending aorta, which is due to the tissue abnormalities associated with a bicuspid aortic valve or to coexisting atherosclerosis or hypertension in patients with calcific disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/1/6169?source=see_link\">",
"       \"Clinical manifestations and diagnosis of bicuspid aortic valve\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the physical examination correlates with the severity of AS, no single finding on physical examination or combination of findings has both a high sensitivity and high specificity for excluding severe AS, particularly in asymptomatic patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/38\">",
"     38",
"    </a>",
"    ]. Echocardiographic data are more reliable. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/3/1082?source=see_link\">",
"     \"Echocardiographic evaluation of the aortic valve\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/39/35445?source=see_link\">",
"     \"Transesophageal echocardiography in the evaluation of aortic valve disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are several important findings on the echocardiogram in patients with AS:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The aortic leaflets are often thickened and calcified, and have a reduced excursion with a small or barely discernible aortic orifice during systole (",
"      <a class=\"graphic graphic_movie graphicRef80369 \" href=\"UTD.htm?37/13/38100\">",
"       movie 5",
"      </a>",
"      and",
"      <a class=\"graphic graphic_movie graphicRef61369 \" href=\"UTD.htm?40/25/41375\">",
"       movie 6",
"      </a>",
"      and",
"      <a class=\"graphic graphic_movie graphicRef59344 \" href=\"UTD.htm?24/5/24660\">",
"       movie 7",
"      </a>",
"      and",
"      <a class=\"graphic graphic_movie graphicRef59538 \" href=\"UTD.htm?21/41/22163\">",
"       movie 8",
"      </a>",
"      ). A reduced orifice size can also be seen in heart failure or other conditions that cause a reduction of blood flow across the aortic valve.",
"     </li>",
"     <li>",
"      When a bicuspid aortic valve is present, systolic images show the two leaflets (and two commissures) of the open valve. A bicuspid valve may appear trileaflet on diastolic images if a raphe is present. Associated aortic root involvement depends on the specific bicuspid valve phenotype (congenital fusion of the right and left versus the right and noncoronary cusps) (",
"      <a class=\"graphic graphic_movie graphicRef66664 \" href=\"UTD.htm?21/52/22351\">",
"       movie 9",
"      </a>",
"      and",
"      <a class=\"graphic graphic_movie graphicRef59607 \" href=\"UTD.htm?27/17/27921\">",
"       movie 10",
"      </a>",
"      and",
"      <a class=\"graphic graphic_movie graphicRef71102 \" href=\"UTD.htm?40/24/41346\">",
"       movie 11",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/1/6169?source=see_link\">",
"       \"Clinical manifestations and diagnosis of bicuspid aortic valve\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The left ventricular chamber is usually normal in size (unless ventricular decompensation has occurred) and has normal systolic function. However, the left ventricular wall is concentrically or uniformly hypertrophied (",
"      <a class=\"graphic graphic_movie graphicRef80369 \" href=\"UTD.htm?37/13/38100\">",
"       movie 5",
"      </a>",
"      and",
"      <a class=\"graphic graphic_movie graphicRef59538 \" href=\"UTD.htm?21/41/22163\">",
"       movie 8",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Doppler echocardiography permits measurement of jet velocity and calculation of the left ventricular-aortic gradient and the valve area, which are the standard parameters used for evaluation of stenosis severity (",
"      <a class=\"graphic graphic_table graphicRef65280 \" href=\"UTD.htm?17/33/17948\">",
"       table 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_waveform graphicRef73624 \" href=\"UTD.htm?6/20/6479\">",
"       waveform 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef52584 \" href=\"UTD.htm?15/32/15887\">",
"       image 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_movie graphicRef68228 \" href=\"UTD.htm?32/18/33070\">",
"       movie 12",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Hemodynamic progression'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/11/1208?source=see_link&amp;anchor=H6#H6\">",
"       \"Aortic valve area in aortic stenosis\", section on 'Echocardiography'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Concurrent aortic regurgitation is present in over 80 percent of patients with AS, but is usually mild. Mitral regurgitation is also common, due to mitral annular calcification and leaflet thickening. The severity of mitral regurgitation is usually mild to moderate and may be exacerbated by the high systolic LV pressure resulting from the outflow obstruction.",
"     </li>",
"     <li>",
"      Doppler echocardiography provides the most reliable noninvasive estimation of the pulmonary artery pressure. The pulmonary artery pressure may be increased in AS because of the chronic elevation in left ventricular diastolic filling pressure. A severe elevation in pulmonary artery pressure (systolic pressure &gt;50 mmHg) occurs in approximately 15 percent of patients [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/47\">",
"       47",
"      </a>",
"      ]. In some cases, pulmonary hypertension is due to coexisting lung disease, rather than to the effects of aortic valve obstruction. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/47/19193?source=see_link\">",
"       \"Overview of pulmonary hypertension in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The 2006 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart Association",
"    <span class=\"nowrap\">",
"     (ACC/AHA)",
"    </span>",
"    guidelines on the management of valvular heart disease included recommendations for the diagnostic evaluation of adolescents and young adults with congenital AS (",
"    <a class=\"graphic graphic_table graphicRef72431 \" href=\"UTD.htm?18/39/19068\">",
"     table 3",
"    </a>",
"    ) and the use of echocardiography for the evaluation and monitoring of older patients with AS (",
"    <a class=\"graphic graphic_table graphicRef80790 \" href=\"UTD.htm?14/18/14635\">",
"     table 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/1/6169?source=see_link\">",
"     \"Clinical manifestations and diagnosis of bicuspid aortic valve\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The recommended frequency of echocardiographic monitoring in adults varies with the severity of aortic stenosis (",
"    <a class=\"graphic graphic_table graphicRef65280 \" href=\"UTD.htm?17/33/17948\">",
"     table 2",
"    </a>",
"    ): every year for severe aortic stenosis, every one to two years for moderate aortic stenosis, and every three to five years for mild aortic stenosis (",
"    <a class=\"graphic graphic_table graphicRef80790 \" href=\"UTD.htm?14/18/14635\">",
"     table 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/33\">",
"     33",
"    </a>",
"    ]. The rationale for monitoring is provided by the marked variability in the rate of disease progression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Evaluation of the aorta",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bicuspid aortic valves are a common cause of aortic stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Relative frequency'",
"    </a>",
"    above.) They are associated with dilatation of the aortic root",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ascending thoracic aorta in the majority of patients. Potential complications include aneurysm formation and dissection. Monitoring in patients with bicuspid aortic valves is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/1/6169?source=see_link\">",
"     \"Clinical manifestations and diagnosis of bicuspid aortic valve\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     Cardiac catheterization",
"    </span>",
"    &nbsp;&mdash;&nbsp;The increased use of echocardiography in AS has reduced the importance of hemodynamic measurements obtained at the time of cardiac catheterization and left ventricular contrast angiography. The 2006",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines on the management of valvular heart disease recommended cardiac catheterization for hemodynamic assessment in only one setting in adults: in symptomatic patients in whom noninvasive tests are inconclusive or provide discrepant results from clinical findings regarding the severity of aortic stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/41/3737?source=see_link&amp;anchor=H2#H2\">",
"     \"Hemodynamics of valvular disorders as measured by cardiac catheterization\", section on 'Valvular aortic stenosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is some risk of cerebral embolization associated with crossing the aortic valve in patients with severe calcific aortic stenosis; as a result, this approach should be avoided in such patients whenever possible [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/42/42665?source=see_link&amp;anchor=H6#H6\">",
"     \"Complications of diagnostic cardiac catheterization\", section on 'Role of valvular aortic stenosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The separate issue of coronary angiography at the time of aortic valve replacement to identify patients who might also benefit from coronary artery bypass graft surgery is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/8/31881?source=see_link&amp;anchor=H20#H20\">",
"     \"Indications for valve replacement in aortic stenosis in adults\", section on 'Aortic valve replacement and CABG'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Coronary angiography was also recommended in patients with apparently mild to moderate AS who have progressive angina, objective evidence of ischemia, or either asymptomatic or symptomatic left ventricular dysfunction (",
"    <a class=\"graphic graphic_table graphicRef66360 \" href=\"UTD.htm?29/4/29772\">",
"     table 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/33\">",
"     33",
"    </a>",
"    ]. In addition, there may be a larger role for cardiac catheterization in adolescents and young adults with congenital aortic stenosis (",
"    <a class=\"graphic graphic_table graphicRef72431 \" href=\"UTD.htm?18/39/19068\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/1/6169?source=see_link\">",
"     \"Clinical manifestations and diagnosis of bicuspid aortic valve\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21855243\">",
"    <span class=\"h2\">",
"     Other tests",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21855299\">",
"    <span class=\"h3\">",
"     Cardiovascular magnetic resonance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiovascular magnetic resonance (CMR) imaging can detect the presence of AS and the anatomic valve area can be measured from short axis views of the valve [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. In addition, velocity-encoded imaging can accurately measure the antegrade velocity through the stenotic valve with the advantage, compared to echocardiography, that it is not angle dependent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A preliminary study suggested that midwall fibrosis detected by late gadolinium enhancement (LGE) on CMR may aid in risk stratification of patients with AS [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/55\">",
"     55",
"    </a>",
"    ] (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/3/34874?source=see_link&amp;anchor=H36992798#H36992798\">",
"     \"Clinical utility of cardiovascular magnetic resonance imaging\", section on 'Late gadolinium enhancement'",
"    </a>",
"    ). A cohort of 143 patients with moderate or severe aortic stenosis underwent CMR and were followed for a mean of two years. There were 27 deaths and 72 patients underwent aortic valve replacement. Compared with the 49 patients with no LGE, the 54 patients with midwall fibrosis had an eight-fold increase in mortality while the 40 patients with an infarct pattern had a six-fold increase in mortality. By multivariate analysis, midwall fibrosis (hazard ratio 5.35; 95% CI 1.16 to 24.56) and left ventricular ejection fraction (hazard ratio 0.96; 95% CI 0.94 to 0.99) were independent predictors of mortality.",
"   </p>",
"   <p>",
"    Despite these observations, CMR evaluation of AS severity is not yet widely accepted, in part due to limited experience and availability. The potential prognostic value of CMR detection of myocardial fibrosis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/3/34874?source=see_link&amp;anchor=H32#H32\">",
"     \"Clinical utility of cardiovascular magnetic resonance imaging\", section on 'Valvular heart disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21855395\">",
"    <span class=\"h4\">",
"     Computed tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both electron beam and rapid multislice chest tomography can provide quantitative evaluation of the amount of valve calcification [",
"    <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. The degree of calcification correlates both with stenosis severity by echocardiography and with clinical outcomes. However, the role of quantitation of valve calcium in clinical decision making has not been defined.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/53/36690?source=see_link\">",
"       \"Patient information: Aortic stenosis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7012307\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There are three primary causes of valvular AS (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Etiology of valvular AS'",
"      </a>",
"      above.):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A congenitally abnormal valve with superimposed calcification (unicuspid or bicuspid) (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/1/6169?source=see_link\">",
"       \"Clinical manifestations and diagnosis of bicuspid aortic valve\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Calcific disease of a trileaflet valve",
"     </li>",
"     <li>",
"      Rheumatic valve disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The pathobiology of calcific aortic valve disease is characterized by three primary processes: lipid accumulation, inflammation, and calcification. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In general, symptoms in patients with aortic stenosis and normal left ventricular systolic function rarely occur until the valve area is &lt;1.0 cm",
"      <sup>",
"       2",
"      </sup>",
"      , the jet velocity is over 4.0",
"      <span class=\"nowrap\">",
"       m/sec,",
"      </span>",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      the mean transvalvular gradient exceeds 40 mm Hg (",
"      <a class=\"graphic graphic_table graphicRef65280 \" href=\"UTD.htm?17/33/17948\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Hemodynamic progression'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with known AS who are followed prospectively, the most common symptoms are decreased exercise tolerance and dyspnea on exertion. Once symptoms develop, even when mild, prompt surgical intervention is needed because average survival without valve replacement is only two to three years, with a high risk of sudden death (",
"      <a class=\"graphic graphic_figure graphicRef83004 \" href=\"UTD.htm?40/22/41327\">",
"       figure 1",
"      </a>",
"      ) (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Symptoms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although the physical examination correlates with the severity of AS, no single finding on physical examination or combination of findings has both high sensitivity and high specificity for excluding severe AS, particularly in asymptomatic patients [",
"      <a class=\"abstract\" href=\"UTD.htm?21/12/21706/abstract/38\">",
"       38",
"      </a>",
"      ]. Echocardiographic data are more reliable. (See",
"      <a class=\"local\" href=\"#H33\">",
"       'Echocardiography'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/1\">",
"      Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005; 111:920.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/2\">",
"      Wallby L, Janerot-Sj&ouml;berg B, Steffensen T, Broqvist M. T lymphocyte infiltration in non-rheumatic aortic stenosis: a comparative descriptive study between tricuspid and bicuspid aortic valves. Heart 2002; 88:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/3\">",
"      Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005; 111:3316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/4\">",
"      Otto CM, Kuusisto J, Reichenbach DD, et al. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994; 90:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/5\">",
"      Olsson M, Thyberg J, Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 1999; 19:1218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/6\">",
"      Olsson M, Dalsgaard CJ, Haegerstrand A, et al. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol 1994; 23:1162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/7\">",
"      O'Brien KD, Kuusisto J, Reichenbach DD, et al. Osteopontin is expressed in human aortic valvular lesions. Circulation 1995; 92:2163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/8\">",
"      Mohler ER 3rd, Adam LP, McClelland P, et al. Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol 1997; 17:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/9\">",
"      Rajamannan NM, Subramaniam M, Rickard D, et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003; 107:2181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/10\">",
"      Mohler ER 3rd, Gannon F, Reynolds C, et al. Bone formation and inflammation in cardiac valves. Circulation 2001; 103:1522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/11\">",
"      Kaden JJ, Bickelhaupt S, Grobholz R, et al. Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis. J Heart Valve Dis 2004; 13:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/12\">",
"      O'Brien KD, Shavelle DM, Caulfield MT, et al. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 2002; 106:2224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/13\">",
"      Helske S, Lindstedt KA, Laine M, et al. Induction of local angiotensin II-producing systems in stenotic aortic valves. J Am Coll Cardiol 2004; 44:1859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/14\">",
"      Kaden JJ, Dempfle CE, Grobholz R, et al. Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis. Atherosclerosis 2003; 170:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/15\">",
"      Jian B, Narula N, Li QY, et al. Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg 2003; 75:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/16\">",
"      Ghaisas NK, Foley JB, O'Briain DS, et al. Adhesion molecules in nonrheumatic aortic valve disease: endothelial expression, serum levels and effects of valve replacement. J Am Coll Cardiol 2000; 36:2257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/17\">",
"      Jian B, Jones PL, Li Q, et al. Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis. Am J Pathol 2001; 159:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/18\">",
"      Aikawa E, Otto CM. Look more closely at the valve: imaging calcific aortic valve disease. Circulation 2012; 125:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/19\">",
"      Dweck MR, Jones C, Joshi NV, et al. Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. Circulation 2012; 125:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/20\">",
"      Agmon Y, Khandheria BK, Meissner I, et al. Aortic valve sclerosis and aortic atherosclerosis: different manifestations of the same disease? Insights from a population-based study. J Am Coll Cardiol 2001; 38:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/21\">",
"      Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997; 29:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/22\">",
"      Briand M, Lemieux I, Dumesnil JG, et al. Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. J Am Coll Cardiol 2006; 47:2229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/23\">",
"      Garg V, Muth AN, Ransom JF, et al. Mutations in NOTCH1 cause aortic valve disease. Nature 2005; 437:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/24\">",
"      McKellar SH, Tester DJ, Yagubyan M, et al. Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms. J Thorac Cardiovasc Surg 2007; 134:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/25\">",
"      Probst V, Le Scouarnec S, Legendre A, et al. Familial aggregation of calcific aortic valve stenosis in the western part of France. Circulation 2006; 113:856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/26\">",
"      Novaro GM, Sachar R, Pearce GL, et al. Association between apolipoprotein E alleles and calcific valvular heart disease. Circulation 2003; 108:1804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/27\">",
"      Ortlepp JR, Schmitz F, Mevissen V, et al. The amount of calcium-deficient hexagonal hydroxyapatite in aortic valves is influenced by gender and associated with genetic polymorphisms in patients with severe calcific aortic stenosis. Eur Heart J 2004; 25:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/28\">",
"      Ortlepp JR, Hoffmann R, Ohme F, et al. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart 2001; 85:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/29\">",
"      Ertas FS, Hasan T, Ozdol C, et al. Relationship between angiotensin-converting enzyme gene polymorphism and severity of aortic valve calcification. Mayo Clin Proc 2007; 82:944.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/30\">",
"      Jin XY, Pepper JR, Gibson DG. Effects of incoordination on left ventricular force-velocity relation in aortic stenosis. Heart 1996; 76:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/31\">",
"      Rallidis L, Naoumova RP, Thompson GR, Nihoyannopoulos P. Extent and severity of atherosclerotic involvement of the aortic valve and root in familial hypercholesterolaemia. Heart 1998; 80:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/32\">",
"      Summers RM, Andrasko-Bourgeois J, Feuerstein IM, et al. Evaluation of the aortic root by MRI: insights from patients with homozygous familial hypercholesterolemia. Circulation 1998; 98:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/33\">",
"      Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118:e523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/34\">",
"      Julius BK, Spillmann M, Vassalli G, et al. Angina pectoris in patients with aortic stenosis and normal coronary arteries. Mechanisms and pathophysiological concepts. Circulation 1997; 95:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/35\">",
"      Davies JE, Sen S, Broyd C, et al. Arterial pulse wave dynamics after percutaneous aortic valve replacement: fall in coronary diastolic suction with increasing heart rate as a basis for angina symptoms in aortic stenosis. Circulation 2011; 124:1565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/36\">",
"      Etchells E, Bell C, Robb K. Does this patient have an abnormal systolic murmur? JAMA 1997; 277:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/37\">",
"      Etchells E, Glenns V, Shadowitz S, et al. A bedside clinical prediction rule for detecting moderate or severe aortic stenosis. J Gen Intern Med 1998; 13:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/38\">",
"      Munt B, Legget ME, Kraft CD, et al. Physical examination in valvular aortic stenosis: correlation with stenosis severity and prediction of clinical outcome. Am Heart J 1999; 137:298.",
"     </a>",
"    </li>",
"    <li>",
"     Chest 1998;113:482.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/40\">",
"      Gersony WM, Hayes CJ, Driscoll DJ, et al. Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation 1993; 87:I121.",
"     </a>",
"    </li>",
"    <li>",
"     Wilson W, Taubert KA, Gewitz M, et al. Prevention of Infective Endocarditis. Guidelines From the American Heart Association. A Guideline From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 115 published online April 19, 2007. www.circ.ahajournals.org/cgi/reprint/CIRCULATIONAHA.106.183095v1 (Accessed on May 04, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/42\">",
"      Vincentelli A, Susen S, Le Tourneau T, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003; 349:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/43\">",
"      Pareti FI, Lattuada A, Bressi C, et al. Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis. Circulation 2000; 102:1290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/44\">",
"      Yoshida K, Tobe S, Kawata M, Yamaguchi M. Acquired and reversible von Willebrand disease with high shear stress aortic valve stenosis. Ann Thorac Surg 2006; 81:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/45\">",
"      Boon A, Lodder J, Cheriex E, Kessels F. Risk of stroke in a cohort of 815 patients with calcification of the aortic valve with or without stenosis. Stroke 1996; 27:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/46\">",
"      Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997; 95:2262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/47\">",
"      Faggiano P, Antonini-Canterin F, Ribichini F, et al. Pulmonary artery hypertension in adult patients with symptomatic valvular aortic stenosis. Am J Cardiol 2000; 85:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/48\">",
"      Shavelle DM, Budoff MJ, Buljubasic N, et al. Usefulness of aortic valve calcium scores by electron beam computed tomography as a marker for aortic stenosis. Am J Cardiol 2003; 92:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/49\">",
"      Messika-Zeitoun D, Aubry MC, Detaint D, et al. Evaluation and clinical implications of aortic valve calcification measured by electron-beam computed tomography. Circulation 2004; 110:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/50\">",
"      Chambers J, Bach D, Dumesnil J, et al. Crossing the aortic valve in severe aortic stenosis: no longer acceptable? J Heart Valve Dis 2004; 13:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/51\">",
"      Omran H, Schmidt H, Hackenbroch M, et al. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet 2003; 361:1241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/52\">",
"      John AS, Dill T, Brandt RR, et al. Magnetic resonance to assess the aortic valve area in aortic stenosis: how does it compare to current diagnostic standards? J Am Coll Cardiol 2003; 42:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/53\">",
"      Friedrich MG, Schulz-Menger J, Poetsch T, et al. Quantification of valvular aortic stenosis by magnetic resonance imaging. Am Heart J 2002; 144:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/54\">",
"      Kilner PJ, Manzara CC, Mohiaddin RH, et al. Magnetic resonance jet velocity mapping in mitral and aortic valve stenosis. Circulation 1993; 87:1239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/12/21706/abstract/55\">",
"      Dweck MR, Joshi S, Murigu T, et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol 2011; 58:1271.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8164 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-60.18.131.125-92069A6D88-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_12_21706=[""].join("\n");
var outline_f21_12_21706=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H7012307\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ETIOLOGY OF VALVULAR AS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Relative frequency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26904730\">",
"      - Pathobiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Progression from aortic sclerosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Association with atherosclerosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Genetic factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Other factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      HEMODYNAMIC PROGRESSION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21855074\">",
"      OTHER CAUSES OF LEFT VENTRICULAR OUTFLOW OBSTRUCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21855144\">",
"      Subvalvular disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21855151\">",
"      Supravalvular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Dyspnea and decreased exercise tolerance",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Dizziness and syncope",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Angina pectoris",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Carotid pulse",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Precordial palpation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Cardiac auscultation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      OTHER CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Sudden cardiac death",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Arrhythmias",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Ventricular arrhythmias",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Endocarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Bleeding tendency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Embolic events",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Coronary disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      TESTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Electrocardiogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Chest radiograph",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Echocardiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Evaluation of the aorta",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      Cardiac catheterization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21855243\">",
"      Other tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21855299\">",
"      - Cardiovascular magnetic resonance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H21855395\">",
"      Computed tomography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7012307\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/8164\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8164|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?15/62/16355\" title=\"diagnostic image 1\">",
"      Supravalvar aortic stenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?10/58/11170\" title=\"diagnostic image 2\">",
"      Aortic root calcification Lat",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?15/32/15887\" title=\"diagnostic image 3\">",
"      CW Doppler AS severe",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8164|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/22/41327\" title=\"figure 1\">",
"      Time course of calcific aortic stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8164|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?13/13/13521\" title=\"movie 1\">",
"      Phonocardiogram calcific AS 3rd left ICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?39/8/40065\" title=\"movie 2\">",
"      Phonocardiogram bicusid AS at 2nd R ICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?43/6/44128\" title=\"movie 3\">",
"      Phonocardiogram of bicuspid AS at apex",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?20/22/20832\" title=\"movie 4\">",
"      Phonocardiogram calcific AS at 2nd right intercostal space",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?37/13/38100\" title=\"movie 5\">",
"      Echocardiogram five chamber view of AS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?40/25/41375\" title=\"movie 6\">",
"      Echocardiogram 5 chamber magnified view of AS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?24/5/24660\" title=\"movie 7\">",
"      Echocardiogram PLAX view of calcific AS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?21/41/22163\" title=\"movie 8\">",
"      Echocardiogram apical long axis view of calcific aortic stenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?21/52/22351\" title=\"movie 9\">",
"      M-mode echocardiogram of AR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?27/17/27921\" title=\"movie 10\">",
"      Bicuspid aortic valve short axis echocardiogram 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?40/24/41346\" title=\"movie 11\">",
"      Bicuspid aortic valve short axis echocardiogram 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?32/18/33070\" title=\"movie 12\">",
"      Calcific aortic stenosis color doppler echocardiogram",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8164|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?42/11/43196\" title=\"table 1\">",
"      Causes LV outflow obstruction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/33/17948\" title=\"table 2\">",
"      Severity of AS in adults",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?18/39/19068\" title=\"table 3\">",
"      ACC AHA evaluate congenital AS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/4/36939\" title=\"table 4A\">",
"      Echo asymptomatic murmurs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/35/17979\" title=\"table 4B\">",
"      Echo symptomatic murmurs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/18/14635\" title=\"table 5\">",
"      ACC AHA echo aortic stenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/4/29772\" title=\"table 6\">",
"      Coronary angio valve disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8164|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?41/58/42922\" title=\"waveform 1\">",
"      LVH tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?41/57/42906\" title=\"waveform 2\">",
"      ECG ST-T changes with LVH tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?6/20/6479\" title=\"waveform 3\">",
"      CW Doppler AS mild",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/13/8410?source=related_link\">",
"      Angiodysplasia of the gastrointestinal tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=related_link\">",
"      Antimicrobial prophylaxis for bacterial endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/11/1208?source=related_link\">",
"      Aortic valve area in aortic stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/24/38279?source=related_link\">",
"      Aortic valve sclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=related_link\">",
"      Auscultation of cardiac murmurs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/56/22410?source=related_link\">",
"      Auscultation of heart sounds",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/8/44169?source=related_link\">",
"      Classification and pathophysiology of von Willebrand disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/50/7978?source=related_link\">",
"      Clinical manifestations and diagnosis of Paget disease of bone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/20/23879?source=related_link\">",
"      Clinical manifestations and diagnosis of acute rheumatic fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/1/6169?source=related_link\">",
"      Clinical manifestations and diagnosis of bicuspid aortic valve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/3/34874?source=related_link\">",
"      Clinical utility of cardiovascular magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/42/42665?source=related_link\">",
"      Complications of diagnostic cardiac catheterization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/3/1082?source=related_link\">",
"      Echocardiographic evaluation of the aortic valve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/13/3285?source=related_link\">",
"      Electrocardiographic diagnosis of left ventricular hypertrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/8/8327?source=related_link\">",
"      Epidemiology and pathogenesis of acute rheumatic fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/15/33013?source=related_link\">",
"      Examination of the arterial pulse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/43/9909?source=related_link\">",
"      Examination of the precordial pulsation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/41/3737?source=related_link\">",
"      Hemodynamics of valvular disorders as measured by cardiac catheterization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/8/31881?source=related_link\">",
"      Indications for valve replacement in aortic stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37274?source=related_link\">",
"      Inherited disorders of LDL-cholesterol metabolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/62/2025?source=related_link\">",
"      Medical management of asymptomatic aortic stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/53/30551?source=related_link\">",
"      Natural history of aortic stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/47/19193?source=related_link\">",
"      Overview of pulmonary hypertension in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/9/5272?source=related_link\">",
"      Pathogenesis and etiology of syncope",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/9/38039?source=related_link\">",
"      Pathophysiology, clinical features, and evaluation of chronic aortic regurgitation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/53/36690?source=related_link\">",
"      Patient information: Aortic stenosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/27/33207?source=related_link\">",
"      Subvalvar aortic stenosis (subaortic stenosis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/52/40774?source=related_link\">",
"      Supravalvar aortic stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/53/36697?source=related_link\">",
"      Surgical procedures for severe chronic mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32954?source=related_link\">",
"      The metabolic syndrome (insulin resistance syndrome or syndrome X)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/39/35445?source=related_link\">",
"      Transesophageal echocardiography in the evaluation of aortic valve disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/59/28600?source=related_link\">",
"      Types and pathophysiology of obstructive hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/28/38345?source=related_link\">",
"      Valvar aortic stenosis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/36/34377?source=related_link\">",
"      Valvular heart disease in elderly adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/59/954?source=related_link\">",
"      Valvular heart disease in patients with end-stage renal disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_12_21707="Hysterectomy outcome PI";
var content_f21_12_21707=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F68886&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F68886&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Frequency of common, severe symptoms before and after hysterectomy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Symptom",
"       </td>",
"       <td class=\"subtitle1\">",
"        Frequency before, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Frequency after, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vaginal bleeding",
"       </td>",
"       <td>",
"        59",
"       </td>",
"       <td>",
"        &lt;1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pelvic pain",
"       </td>",
"       <td>",
"        63",
"       </td>",
"       <td>",
"        8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Back pain",
"       </td>",
"       <td>",
"        43",
"       </td>",
"       <td>",
"        17",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Activity limitation",
"       </td>",
"       <td>",
"        58",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sleep disturbance",
"       </td>",
"       <td>",
"        41",
"       </td>",
"       <td>",
"        21",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fatigue",
"       </td>",
"       <td>",
"        70",
"       </td>",
"       <td>",
"        25",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abdominal bloating",
"       </td>",
"       <td>",
"        48",
"       </td>",
"       <td>",
"        12",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Urinary incontinence",
"       </td>",
"       <td>",
"        20",
"       </td>",
"       <td>",
"        8",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from data in Kjerulff, KH, Langenberg, PW, Rhodes, JS, et al. Obstet Gynecol 2000; 95:319.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_12_21707=[""].join("\n");
var outline_f21_12_21707=null;
var title_f21_12_21708="Normal urinary solute value in children random urine collection";
var content_f21_12_21708=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F82389&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F82389&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Normal urinary solute value in children based on measurements of solutes and creatinine from a single random urine collection",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Age",
"       </td>",
"       <td class=\"subtitle1\">",
"        mg/mg",
"       </td>",
"       <td class=\"subtitle1\">",
"        Age",
"       </td>",
"       <td class=\"subtitle1\">",
"        mmol/mmol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Calcium/Creatinine",
"       </td>",
"       <td>",
"        0 to 6 mo",
"       </td>",
"       <td>",
"        &lt;0.8",
"       </td>",
"       <td>",
"        0 to 6 mo",
"       </td>",
"       <td>",
"        &lt;2.24",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6 to 12 mo",
"       </td>",
"       <td>",
"        &lt;0.6",
"       </td>",
"       <td>",
"        6 to 12 mo",
"       </td>",
"       <td>",
"        &lt;1.68",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2 to 18 yr",
"       </td>",
"       <td>",
"        &lt;0.2",
"       </td>",
"       <td>",
"        2 to 18 yr",
"       </td>",
"       <td>",
"        &lt;0.56",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        Oxalate/Creatinine",
"       </td>",
"       <td>",
"        0 to 6 mo",
"       </td>",
"       <td>",
"        &lt;0.3",
"       </td>",
"       <td>",
"        &lt;1 yr",
"       </td>",
"       <td>",
"        &lt;0.06",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6 mo to 4 yr",
"       </td>",
"       <td>",
"        &lt;0.15",
"       </td>",
"       <td>",
"        1 to 5 yr",
"       </td>",
"       <td>",
"        &lt;0.04",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &gt;4 yr to adult",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        5 to 12 yr",
"       </td>",
"       <td>",
"        &lt;0.03",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &gt;12 yr",
"       </td>",
"       <td>",
"        &lt;0.01",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cystine/Creatinine",
"       </td>",
"       <td>",
"        All ages",
"       </td>",
"       <td>",
"        &lt;0.02",
"       </td>",
"       <td>",
"        All ages",
"       </td>",
"       <td>",
"        &lt;0.01",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Uric acid/glomerular filtration rate*",
"       </td>",
"       <td>",
"        &gt;3 yr",
"       </td>",
"       <td>",
"        &lt;0.56 mg uric acid/dL of glomerular filtrate",
"       </td>",
"       <td>",
"        &gt;3 yr",
"       </td>",
"       <td>",
"        &lt;0.03 mmol uric acid/dL of glomerular filtrate",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Uric acid/glomerular filtration rate calculated using the following equation, where UCr and PCr are the urine and plasma creatinine concentrations, respectively: Uric acid/GFR, mg/dL = Urine Uric Acid &divide; UCr x PCr.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_12_21708=[""].join("\n");
var outline_f21_12_21708=null;
var title_f21_12_21709="Papules";
var content_f21_12_21709=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F61037&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F61037&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of papules",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Isolated papules",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Acrochordon",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Actinic keratosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Angiofibroma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Appendageal tumors (benign or malignant)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Bacillary angiomatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Basal cell carcinoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Chondrodermatitis nodularis helicis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Dermatofibroma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Fungal infections (early)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hemangioma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Keratoacanthoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Melanoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Milia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Molluscum contagiosum",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Neurofibroma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Nevus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pyogenic granuloma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sebaceous hyperplasia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Seborrheic keratosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Squamous cell carcinoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Venous lake",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Wart",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Papular eruptions",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Acne rosacea",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Acne vulgaris",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Appendageal tumors (usually benign)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Arthropod bite",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Bacillary angiomatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Dermatomyositis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Drug eruption",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Eczematous dermatitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Flat warts",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Folliculitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Granuloma annulare",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Keratosis pilaris",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lichen nitidus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lichen planus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lichen sclerosus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lupus erythematosus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Miliaria",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Molluscum contagiosum",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Neurofibromatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pediculosis corporis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Perioral dermatitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pityriasis rosea",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Polymorphous light eruption",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Psoriasis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sarcoidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sarcoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Scabies",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Syphilis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Urticaria",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Vasculitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Viral exanthem",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Xanthoma",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_12_21709=[""].join("\n");
var outline_f21_12_21709=null;
var title_f21_12_21710="Relationship between ST depression and mortality unstable angina";
var content_f21_12_21710=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F58461&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F58461&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    ST segment depression on the initial ECG is associated with mortality in unstable angina",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 444px; height: 350px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In the GUSTO-IIb trial of 8001 patients with unstable angina, the presence of &ge;2 mm ST segment depression in &ge;2 contiguous leads on the initial ECG was associated with an increased one-year mortality (14 versus 4.4 percent without ST segment depression, p&lt;0.05).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Kaul P, Fu Y, Chang WC, et al. J Am Coll Cardiol 2001; 38:64.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_12_21710=[""].join("\n");
var outline_f21_12_21710=null;
var title_f21_12_21711="Salter II ankle";
var content_f21_12_21711=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F56106&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F56106&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Salter-Harris II fracture of the tibia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 183px; height: 468px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The fracture line extends above the growth plate (black arrow) creating a triangular fragment also known as the Thurston-Holland sign.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Boutis, K. Common Pediatric Fractures Treated with Minimal Intervention. Pediatr Emerg Care 2010. Copyright &copy; 2010 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_12_21711=[""].join("\n");
var outline_f21_12_21711=null;
